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Skeletal muscle regeneration provides a powerful model to study the 
cellular and molecular mechanism governing stem cell function since the whole 
process is mediated by a population of muscle-resident stem cells called satellite 
cells. The overall aim of this dissertation is to explore the roles of Notch signaling 
and a novel gene (Bex1) in satellite cell function and skeletal muscle 
regeneration.  
The first part of this thesis is to examine how the Notch signaling pathway 
regulates the satellite cell self-renewal in a disease model. The MDX mouse is a 
well-established model for Duchenne muscular dystrophy (DMD) and 
characterized by progressive muscle degeneration and regeneration. Here, I 
showed that the number and activity of satellite cells in MDX mice were reduced 
in an age-dependent manner. Given that satellite cells can self-renew to maintain 
the homeostasis, I further demonstrated that the self-renewal capacity was 
defective in MDX mice. As the Notch signaling pathway has been reported to 
regulate satellite cell quiescence, I continued to confirmed that the self-renewal 
defect was due to the perturbed Notch in MDX satellite cells. Furthermore, I 
xv 
 
attempted to genetically activate the Notch signaling pathway in satellite cells to 
improve muscle regeneration in MDX mice. Surprisingly, although the Notch 
activation increased the satellite cell number and rescued the self-renewal 
defects, it did not contribute to muscle regeneration. Nevertheless, this study 
extends our understanding of the Notch signaling pathway in the activity of 
satellite cells and in muscle regeneration.  
The second part of this dissertation focuses on the roles of Bex1 in muscle 
regeneration. Bex1 is a novel gene with unknown functions in skeletal muscles. I 
first found that Bex1 was temporarily expressed in myogenic cells with a nuclear-
cytoplasmic trafficking pattern during embryonic development and postnatal 
regeneration. The exclusive expression of Bex1 in differentiated myocytes 
suggests that Bex1 may play unknown roles in regulating myogenic 
differentiation. Previous studies suggested that Bex1 could regulate neuron cell 
cycle withdrawal. Here I demonstrated that Bex1 participated in myogenic 
differentiation independent of the cell cycle withdrawal. Instead, I showed that 
Bex1 promoted myoblast-myotube fusion in vitro and the regulation was 
independent of myogenic differentiation per se. However, Bex1 knockout mice 
appeared normal and did not exhibit obvious defects in the skeletal muscle. This 
study characterized the novel function of Bex1 in the myogenesis and facilitated 
the understanding of myoblast fusion process. 
Collectively, the findings about how Notch signaling and Bex1 regulate the 
function of satellite cells as well as muscle regeneration derived from this 
dissertation will extend our understanding of the cellular and molecular 
xvi 
 
mechanism of muscle regeneration. Consequently, this dissertation can shed 




CHAPTER 1. INTRODUCTION 
1.1 Skeletal Muscle Characteristics 
Skeletal muscle constitutes around 50% of body mass and is the largest 
organ in our bodies (Huard et al., 2002). Under normal conditions, skeletal 
muscles have relatively uniform structure, composed of numbers of myofibers. 
Bundles of longitudinally aligned muscle fibers wrapped by extracellular matrix 
(ECM) are attached to either tendons or bones through myotendinous junctions, 
with blood vessels supplying nutrients and oxygen inside. Besides, adult muscle 
tissue contains a variety of interstitial and vessel-associated cells that display 
little mitotic activity under resting conditions. Different types of muscles have their 
unique structure and composition to fulfil their own specialized functions.  
The classic functions of skeletal muscle are posture behavior, locomotive 
movement, and respiration. It is well established that skeletal muscles can 
contract and generate force through the “sliding mechanism” of myosin-rich thick 
filament over actin-rich thin filament upon neuronal stimulation (Huxley, 2000). 
Due to different requirements of muscle activities, the muscle fibers themselves 
are very heterogeneous in terms of structural and functional properties, referred 
as muscle fiber phenotype. Generally speaking, each individual skeletal muscle 
is a mixture of myofibers, ranging from a fast-contracting but easy-to-fatigue fiber 
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type to a slow-contracting but fatigue-resistant fiber type (Table 1.1). The overall 
contractile property of each individual skeletal muscle is dependent on the 
proportion of different fiber types. The regulatory mechanism of muscle fiber type 
diversity has been under intensive studies in the past few decades. Motor neuron 
has been demonstrated to play key roles in the remodeling process of muscle 
fiber type distribution (Calabria et al., 2009). The precise mechanism still remains 
elusive (Cavanaugh et al., 2012; Windisch et al., 1998). Taken together, the 
functional properties of skeletal muscles depend on a complex framework of 
muscle fibers, motor neuron, blood vessel and connective tissues.  
Moreover, skeletal muscles play paramount roles in regulating the 
metabolism through uptaking glucose from the blood (Zurlo et al., 1990). Skeletal 
muscle metabolism is under hormonal control. Under fasting and resting 
conditions, blood glucose is mainly consumed by the brain and gut. In contrast, 
under the stimulus of insulin, skeletal muscles uptake 75% of blood glucose after 
a meal. Exercise training is another regulatory factor of skeletal muscle 
metabolism. For instance, endurance training increases the mitochondria content 
of skeletal muscles and up-regulates the insulin-sensitive glucose transporter, 
GLUT4 (Lessard et al., 2007; Ren et al., 1994). Loss of muscle mass under the 
circumstances of aging or degenerative myopathy can also lead to metabolic 
syndromes (Biolo et al., 2014). Due to the large volume of skeletal muscles, their 
metabolism affects the metabolic condition of the whole organism. As such, 
skeletal muscle is the primary site of insulin resistance under many metabolic 
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diseases conditions, including type 2 diabetes and obesity (DeFronzo and 
Tripathy, 2009).  
1.2 Skeletal Muscle Development 
In vertebrates, skeletal muscles are derived from paraxial mesoderm, which 
segregates into somites, including sclerotome and dermomyotome (Christ and 
Ordahl, 1995). The sclerotome, the ventral part of the somites, gives rise to the 
cartilage and bone while the dermomyotome, the dorsal part of the somites, 
contributes to the skeletal muscles of the body and limbs. During the 
embryogenesis, the muscle progenitor cells delaminate from dermomyotome and 
migrate to the limb bud, where they proliferate, commit to myogenic lineage and 
differentiate into skeletal muscle.  
A number of transcriptional factors have been found to coordinately 
regulate the progression of myogenic lineage. Importantly, the embryonic 
progenitors can be characterized by Pax3/Pax7 expression. Then the myogenic 
commitment of muscle progenitor cells requires the up-regulation of two basic 
helix-loop-helix transcriptional factors, Myf5 and MyoD. These transcriptional 
factors belong to the muscle regulatory factor family (MRFs). In the absence of 
these two factors, those cells that originally develop to the muscles remain 
multipotent and adopt other cell fates, indicating the indispensable roles in 
muscle cell specification (Kablar et al., 1998; Rudnicki et al., 1993). In the 
presence of Myf5 alone, the initiation of myogenesis is delayed, suggesting that 
Myf5 itself can not sufficiently regulate the onset of myogenesis (Kablar et al., 
1997). After the up-regulation of Myf5 and MyoD, cells proceed to the myoblast 
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stage. Then the myoblasts undergo extensive proliferation under the control of a 
number of regulatory factors, including Myf5 and MyoD. During the proliferation 
stage, some myoblasts withdraw from cell cycle and start to express some late-
stage MRFs, myogenin and MRF4. The expression of myogenin and MRF4 
qualifies a cell as a myocyte, referring to a terminally differentiated muscle cell. 
Both myogenin and MRF4 play essential roles in determining muscle 
differentiation program, as indicated by severe defects of muscle development in 
the myogenin and MRF4 knock-out mice. The myogenin knock-out mice die at 
the embryo stage with almost total loss of myofiber formation (Hasty et al., 1993; 
Nabeshima et al., 1993). The MRF4 knock-out mice exhibit different phenotypes, 
depending on which alleles were deleted (Patapoutian et al., 1995; Yoon et al., 
1997; Zhang et al., 1995). Nevertheless, those phenotypes all indicate the role of 
MRF4 in the late stage of myogenesis. With the myogenesis proceeding, the 
myocytes fuse to each other to form primary muscle fibers initially. Under the 
formation of innervations, another wave of myoblast fusion gives rise to the 
secondary muscle fibers. Subsequently, the muscle mass grows extensively 
during the fetal period and postnatally. During this muscle development process, 
it is noteworthy that some myoblast did not differentiate to myocyte but withdraw 
from cell cycle and back to quiescence. Those cells are located between basal 
laminin and muscle fiber membrane, defined as satellite cells. They are regarded 
as the adult muscle progenitor cells which can initiate the postnatal myogenesis 
(Anderson, 2006; Cheung and Rando, 2013; Kuang and Rudnicki, 2008; Wagers 
and Conboy, 2005). 
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1.3 Skeletal Muscle Regeneration 
Under normal conditions, skeletal muscles are relatively stable with little 
turnover of myonuclei, no more than 1-2 percent per week (Schmalbruch and 
Lewis, 2000). However, skeletal muscles are very susceptible to injuries. In 
sports, muscle injuries are very common, covering 10-55 percent of all sustained 
injuries (Beiner and Jokl, 2001; Best and Hunter, 2000; Garrett, 1996; Huard et 
al., 2002). Skeletal muscle injuries can result from a variety of reasons, including 
contusion, strain, laceration, or a mixture of these reasons. As a matter of fact, 
more than 90 percent of muscle injuries are contusions and strains, which mostly 
lead to physical trauma without significant muscle loss (Beiner and Jokl, 2001; 
Counsel and Breidahl, 2010). Under these situations, skeletal muscles have a 
robust capacity to initiate a highly orchestrated regeneration process involving 
various cellular responses to prevent further muscle loss. 
In spite of the types or severity of muscle injuries, muscle regeneration 
follows a stereotype, which can be generally divided into two phases listed as 
follows. 
i. The decomposition and inflammatory phase characterized by the necrosis 
of muscle fibers and the activation of inflammatory responses. 
ii. The repair and remodeling phase characterized by the phagocytosis of 
necrotic muscle fibers, generation of new muscle fibers by myogenic cells 
and formation of a tissue scar. 
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1.3.1 The Degeneration Phase   
Muscle degeneration starts with the necrosis of damaged muscle fibers. 
Following muscle injury, the sarcolemma of muscle fibers are disrupted, leading 
to the increased muscle fiber permeability. Consequently, the intracellular 
proteins of muscle fibers can be released to the extracellular environment, such 
as creatine kinase. The expression of creatine kinase is usually restricted to the 
cytosol of muscle fibers. Therefore its elevated level in serum can indicate the 
occurrence of lesions of the muscle cell membrane (Coulton et al., 1988; Percy 
et al., 1979). Similarly, it was recently demonstrated that the serum levels of 
several muscle specific RNAs (myoMIRs), including mir1, mir206 and mir133, 
can also serve as biomarkers for muscle degeneration (Mizuno et al., 2011; 
Zaharieva et al., 2013). On the other hand, some extracellular substances may 
diffuse into the muscle fibers. Based on this assumption, various dyes have been 
developed to faithfully mark the degenerated fibers since they can be easily 
absorbed by damaged muscle fibers (Hamer et al., 2002; Palacio et al., 2002).  
The most significant event due to the increased permeability is the influx 
of calcium or calcium release from sarcoplasmic reticulum. The loss of calcium 
homeostasis leads to activation of calcium-dependent proteolysis and promotes 
the rapid disintegration of myofibrils.  For instance, calpains are calcium-
activated proteases and play key roles in the decomposition of myofibril and 
cytoskeletal proteins (Belcastro et al., 1998).  
During the early phase of muscle degeneration, the degradation of muscle 
fibers is accompanied with the infiltration of inflammatory cells. Previous studies 
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have demonstrated that the injured muscle fibers can release signals to activate 
the inflammatory cells residing in the muscles. Afterwards, those local 
inflammatory cells can continue to recruit leukocyte cells to the damaged sites 
via the chemotactic machinery. Specifically, neutrophils and macrophages are 
two major inflammatory cells in response to muscle injury (Arnold et al., 2007; 
Pizza et al., 2005).  
Upon muscle damage, neutrophils migrate rapidly to the injury site within 6 
hours, which evokes the local inflammation response. It is well established that 
neutrophils have a robust capacity to produce reactive oxygen species (ROS). 
Therefore as the neutrophils function, the dramatic increase of ROS levels speed 
up the disruption of muscle fiber structure (Fielding et al., 1993; Orimo et al., 
1991). Subsequently, neutrophils are replaced by macrophages, the most 
predominant inflammatory cells invading injury sites. Basically, two distinct 
macrophages function in the muscle regeneration. At first, M1 macrophages 
characterized by the surface marker CD68+/CD163-, reach the concentration 
peak within 24 hours post onset of muscle injury and decrease rapidly afterwards. 
These M1 macrophages can secrete pro-inflammatory cytokines to promote 
inflammation and phagocytize cellular debris. Then M2 macrophage, 
characterized by the surface maker CD68-/CD163+, secretes anti-inflammatory 
cytokines, which sustain until the termination of the inflammation (Cantini et al., 
2002; Lescaudron et al., 1999; Sonnet et al., 2006).  
It is worth mentioning that both neutrophils and macrophages have 
significant roles in regulating the behavior of satellite cells. In detail, neutrophils 
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can activate satellite cells to the injury sites while macrophages can regulate the 
proliferation and differentiation of satellite cells (Merly et al., 1999; St Pierre 
Schneider et al., 2002), both of which prepare muscle tissue to proceed to the 
next stage, muscle repair phase. 
1.3.2 The Repair Phase   
Skeletal muscle regeneration has drawn intense attention for quite a long 
time in that muscle regeneration recapitulates embryonic myogenesis to some 
extent, which provides a powerful model to study muscle development. Long-
standing histological characteristics are still being utilized to distinguish 
regenerating muscle fibers, such as the relatively smaller caliber and centrally 
located nuclei (Hall-Craggs and Seyan, 1975).  
The muscle regeneration is a complex but highly synchronized process. 
The hallmark of this stage is represented by the extensive cell proliferation 
(Grounds et al., 2002; Hawke and Garry, 2001). During the regeneration process, 
various types of cells infiltrate in the injury sites, including satellite cells, 
inflammatory cells, blood vessel cells, neuron cells and so forth. Satellite cells 
migrate to the injury sites and differentiate to myoblasts. These myoblasts can 
undergo extensive proliferation to reach the sufficient cell number, which is 
extremely important for muscle regeneration, as indicated by the reduction of 
regeneration capacity after treated with proliferation inhibitors or irradiation 
(Quinlan et al., 1995; Wakeford et al., 1991; Weller et al., 1991). Those large 
quantities of myoblasts can either fuse to the existing muscle fibers for repair or 
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fuse with each other to form new muscle fibers (Darr and Schultz, 1987; Snow, 
1978). 
Of note, the myoblasts are not the only source of progenitor cells which are 
responsible for muscle regeneration. This raises intense interest and controversy 
concerning whether and how other muscle-derived stem cells and circulating 
progenitor cells can contribute to the muscle regeneration. To date, there are 
several types of cells isolated from skeletal muscles, which have been 
demonstrated to give rise to myogenic lineage cells, including bone marrow stem 
cells, muscle side population cells, PW1+ interstitial cells, mesoangioblasts, 
pericytes, and post-natal muscle derived stem cells, and CD133+ cells and so 
forth (Lee et al., 2000; Peault et al., 2007; Peng and Huard, 2004). Currently, it 
remains unknown how significantly these cells contribute to myogenic 
differentiation.  
Among those different cell populations, post-natal muscle derived stem 
cells displays several advantages over other cell populations in cell 
transplantation treatment, including remarkable multipotency and long-term 
survival rate (Cao et al., 2003; Deasy et al., 2005; Lee et al., 2000). In addition, 
the origin of these post-natal muscle derived stem cells has been a topic of great 
interest. Emerging evidences show that those cells are from vascular 
endothelium (Tavian et al., 2005), suggesting that augmenting vascular supply to 
the wound area may be conducive to muscle regeneration.   
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1.4 Satellite Cells 
Satellite cells were first observed around half a century ago (Mauro, 1961). 
These cells have been regarded as muscle stem cells in that satellite cells have 
been demonstrated to have the capability to replenish themselves and give rise 
to myogenic progeny (Bischoff, 1975; Collins et al., 2005; Konigsberg et al., 1975; 
Kuang et al., 2007; Lipton and Schultz, 1979; Montarras et al., 2005; Moss and 
Leblond, 1971; Sherwood et al., 2004). The identification of satellite cells raised 
them as the top candidate for post-natal muscle growth and regeneration. Indeed, 
they do play indispensable roles in muscle regeneration under a complex 
regulatory network, which has stimulated researchers to develop cell-based 
strategies to treat degenerative muscle diseases, such as Duchnne Muscular 
Dystrophy. However, the efficiency of these strategies is limited due to the low 
survival rate and migration capacity of the transplanted cells. Therefore it is 
imperative to make a more comprehensive understanding about satellite cell 
characteristics in order to manipulate quiescence, proliferation and differentiation 
of satellite cells. 
1.4.1 Identification of Satellite Cells   
Satellite cells can be identified based on a unique location with the 
perspective of anatomy. They are located between the basal lamina and the 
muscle fiber membrane along the whole fiber. Under the electron microscope, 
satellite cells with the “wedge” appearances exhibit condensed interphase 
chromatin, which is consistent with the notion that most satellite cells stay in the 
quiescent state and are transcriptionally inactive in the resting muscles (Mauro, 
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1961; Schultz et al., 1978). In addition, satellite cells can be identified in single 
fibers isolated from skeletal muscles through immuno-fluorescence imaging, 
which is dependent on specific biomarkers. In adult skeletal muscle, nearly every 
satellite cell expresses the paired box 7 (Pax7), which has been well-accepted as 
the canonical biomarker for satellite cells (Seale et al., 2000). Besides, a number 
of transcriptional factors have been utilized in identification of satellite cells, such 
as Pax3 and Myf5 (Buckingham et al., 2003; Cornelison and Wold, 1997). Also, 
some membrane proteins have been implicated in the identification of satellite 
cells, such as cell surface attachment receptor alpha7-intergin (Burkin and 
Kaufman, 1999; Gnocchi et al., 2009) and cell adhesion protein M-cadherin 
(Irintchev et al., 1994). It is noteworthy that some of these aforementioned 
markers can also be expressed in other types of cells. Therefore, it is necessary 
to identify satellite cells with combined fluorescence labeling. 
1.4.2 Niche Regulation of Satellite Cells   
In adult skeletal muscles, satellite cells are a major source for muscle 
regeneration. In resting conditions, satellite cells are mitotically inactive. Upon 
injury, satellite cells undergo a process of cytoplasmic volume expansion and 
heterochromatin reduction to become mitotically active. After satellite cells enter 
the cell cycle, they start to up-regulate the expression level of the basic helix-
loop-helix transcriptional factors Myf5 and MyoD then progress to the highly 
proliferative myoblasts. During the proliferation, some cells withdraw from the cell 
cycle and start to express myogenin, subsequently differentiating to the new 
muscle fibers while the others lose their myogenic signature by down regulating 
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the expression level of MyoD and return to the quiescent state to replenish 
satellite cell pools (Bentzinger et al., 2012). During the whole process of muscle 
regeneration, the behaviors of satellite cells, including self-renewal, proliferation 
as well as differentiation, are under a precisely coordinated regulation by the 
surrounding cells which constitute the satellite cell niche. 
In adult skeletal muscles, the total number of satellite cells remains 
relatively constant even with multiple rounds of muscle injury and repair. This 
homeostasis is largely attributable to the self-renewal capacity (Collins et al., 
2005). The regulation of self-renewal is predominantly dependent on the extrinsic 
factor released by the surrounding cells residing in the satellite cell niche. Indeed, 
the cellular constituents of satellite cell niche are under a dynamic state. In 
particular, the components of quiescent satellite cells niche are significantly 
different from those of activated satellite cells niche. When satellite cells are 
quiescent, the satellite cell niche contains relatively less cell types, such as 
muscle fibers and vessel-associated cells.  
Besides, this microenvironment remains static and exerts effects on 
maintenance of satellite cell quiescence through a variety of signaling pathways. 
Previous studies have corroborated that Notch signaling pathway plays key roles 
in the maintenance of satellite cell quiescence, wherein the genetic deletion of 
Rbpj, a main effecter of the Notch signaling pathway, activates satellite cells 
significantly (Bjornson et al., 2012; Mourikis et al., 2012). Considering the relative 
few cell types in the quiescent satellite cell niche, the Notch regulation may be 
derived from the muscle fibers within the satellite cell niche.  
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During cell proliferation, apart from a small proportion of satellite cells 
return to the quiescence, the majority of satellite cells remain active and further 
become more differentiated myogenic cells. This process is also under the 
regulation of circumambient cells in the niche. However, comparing to the 
quiescent niche, the niche of activated satellite cells becomes much more 
complicated with a spectrum of infiltrating cells.  
First of all, immune cells play critical roles in regulating the behavior of 
activated satellite cells, also called myoblasts. In response to muscle injury, 
varieties of immune cells are quickly recruited to the wound sites and infiltrate to 
the niche. In particular, the predominant immune cells invading the injury sites 
are macrophages, basically with two subtypes, M1 and M2. M1 macrophages 
can promote myoblast proliferation while M2 can induce myoblast differentiation 
(Deng et al., 2012; Ruffell et al., 2009). This is supported by the observation that 
M1 macrophages accumulate close to the proliferating myoblast while M2 
macrophages are proximate to the differentiating myogenic cells (Saclier et al., 
2013).  
Secondly, fibrogenic cells are also major contributors involved in the niche 
regulation. It is well agreed that the extracellular matrix (ECM) play key roles in 
regulating satellite cell behaviors. During muscle regeneration, ECM in the niche 
is largely and dynamically reorganized (Goetsch et al., 2003). In this process, 
fibrogenic cells including fibroblast and FAPs (fibro/adipogenic progenitors) can 
contribute to the deposition of several ECM components, such as different 
collagen isoforms, which participate in the niche regulation. It is noteworthy that 
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the FAPs and the myogenic cells can interplay with each other. FAPs can 
secrete IL6 to induce myogenic differentiation while the formation of myotube 
inhibits the differentiation of FAPs to adipocytes (Joe et al., 2010; Uezumi et al., 
2010). In addition, the endothelial and periendothelial cells as well as the muscle 
lineage cells all play important roles in the niche regulation of activated myoblast 
(Abou-Khalil et al., 2010).  
Due to the complicated constituents of the activated niche, the 
mechanisms that integrate different cell types are highly complex and further 
studies will unravel promising concepts in basic stem cell biology and also 
provide therapeutic avenues for muscular diseases. 
1.4.3 Heterogeneity of Satellite Cells   
Satellite cells were first considered as a homologous population of cells, 
which are committed muscle progenitor cells. As technology advances, emerging 
evidence has demonstrated that satellite cells are a heterogeneous group with 
respective to several characteristics, such as gene expression profiles, myogenic 
differentiation potential and intrinsic self-renewal capacity. 
As for the gene expression profile of satellite cells, it is worth mentioning 
that the satellite cells do not always express those aforementioned satellite cell 
markers. For instance, examination of the aforementioned markers, CD34 and 
M-cadherin, revealed that a group of satellite cells are lack of those markers 
(Beauchamp et al., 2000). Recently, several novel biomarkers for satellite cells 
have been discovered with different expression patterns. The nuclear envelope 
proteins lamin A/C and emerin were universally found to be expressed in 
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quiescent and activated satellite cells whereas Jagged-1, a Notch ligand, was 
preferably expressed in activated satellite cells (Gnocchi et al., 2009). Therefore, 
the molecular signatures of satellite cells vary greatly. The combination of those 
biomarkers may have great implication in delineating the subpopulation of 
satellite cells and further interpreting the biological function of different 
subpopulations. However, the biological significance of this heterogeneity still 
needs to be clarified.  
Satellite cells are very heterogeneous in their propensity of myogenic 
differentiation. It was observed that satellite cells from different types of muscles, 
including tibialis anterior (TA), extensor digitorum longus (EDL) and soleus, can 
contribute to the muscle regeneration differently after transplantation into 
MDX/nude mice (Collins et al., 2005). This result implies that the different 
sources of satellite cells are distinct inherently in the potential of myogenic 
proliferation/differentiation. It can be supported by another observation of varied 
levels of Myf5 in satellite cells, with Myf5 heterozygous cells more committed to 
myogenic differentiation compare to wild type control (Gayraud-Morel et al., 
2012). This heterogeneity of satellite cells in myogenic differentiation may have a 
great advantage to effectively balance between satellite cells pool maintaining 
and myogenic differentiation requirement. 
Another evidence of satellite cells heterogeneity comes from their intrinsic 
self-renewal activity. It has been corroborated that satellite cells are 
heterogeneous based on the expression level of Myf5, one of the earliest 
transcriptional factors for myogenic commitment (Kuang et al., 2007). In detail, 
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Myf5- satellite cells defined a 10% subpopulation while Myf5+ satellite cells 
represent the other 90%. It has been demonstrated that the Myf5- satellite cells 
can give rise to Myf5+ cells, indicating a hierarchical relationship between those 
two subpopulations. Cell transplantation experiments demonstrated that Myf5- 
satellite cells can not only undergo myogenic differentiation but also replenish 
satellite cell pools while Myf5+ satellite cells cannot self-renew but readily 
differentiate for muscle regeneration, which suggests that the self-renewal 
capacity resides in the Myf5- satellite cell subpopulation rather than Myf5+ cells. 
Altogether, these observations revealed the heterogeneity of self-renewal 
capacity residing in satellite cells. In this way, only a paucity of satellite cells can 
be regarded as true stem cells.  
In summary, a variety of studies have substantiated that satellite cells are 
a very heterogeneous population. However, the biological significance of this 
heterogeneity remains poorly understood. Moreover, the intrinsic difference 
between these heterogeneous subpopulation at the molecular and functional 
levels needs to further clarified, which will facilitate in elucidating the mechanisms 
defining the different subpopulations as well as manipulating satellite cell 
behaviors in muscle regeneration. 
1.4.4 Mechanisms of Satellite Cell Self-renewal   
Due to the critical roles of self-renewal, the mechanism governing self-
renewal has drawn intense attention in the field. In general, it was proposed that 
satellite cells can replenish themselves either through an asymmetrical division 
generating one quiescent daughter cell and the other differentiating daughter cell 
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or through a stochastic process wherein the progeny cells are the same at first 
but they take different cell fates afterwards.  
Emerging studies have demonstrated that satellite cells undergo self-
renewal through asymmetrical cell division. One of the evidence is based on the 
distribution of Numb, one cell fate determinant, in the daughter cells after cell 
division. It was observed that Numb is asymmetrically distributed in some but not 
all satellite cells (Conboy and Rando, 2002). In line with this observation, by 
BrdU labeled DNA strand segregation experiment, it was discovered that all “old” 
template DNA strands are co-segregated to the more stem-like daughter cells 
expressing the stem cell marker Sca1. Concomitantly, all “younger” template 
DNA strands are inherited by more differentiating daughter cells expressing the 
differentiation marker Desmin (Conboy et al., 2007). Based on the “immortal DNA 
strand” theory, the retention of old DNA strand can protect stem cells from 
accumulating mutations during DNA replication. Furthermore, it has been directly 
observed that the non-committed Pax7+Myf5- satellite cell can divide 
asymmetrically into two daughter cells with different orientation in the satellite cell 
niche, wherein one non-committed Pax7+Myf5- daughter cell is exposed to the 
basal lamina and the other committed Pax7+Myf5+ daughter cell is exposed to 
the host myofiber (Kuang et al., 2007).  
In summary, through asymmetrical cell division, satellite cells can 
continuously replenish satellite cell pools in the course of muscle regeneration. 
This asymmetrical division pattern has been proposed to be dependent on the 
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different signals. But it remains unclear which signals play predominant roles and 
how these signals coordinate with each other to determine satellite cell fates.  
1.5 Duchenne Muscular Dystrophy 
During the contraction of muscle fibers, the fibers have a particular protein 
complex structure to buffer against mechanical stress. Genetic mutation of the 
elements of the complex can cause muscular dystrophy with different extents in 
term of onset age and dysfunctional muscles as well as severity, depending on 
how the mutated product affects the mechanosensory signaling network. Due to 
the genetic defects, muscular dystrophy is characterized by the progressive 
muscle weakness and degeneration. However, muscles have multifaceted repair 
system for regeneration. Upon injury, muscles can readily response to the stimuli 
and initiate a series of orchestrated events to fulfill the regeneration process. 
Thus, the pathophysiological hallmark of muscle dystrophy is repetitive muscle 
necrosis and regeneration. With the diseases advances, muscle degeneration 
gradually overtakes the regenerative capacity. Consequently, the muscle fibers 
are replaced by the fibrotic and adipose tissue, which leave muscle increasingly 
weak and eventually nonfunctional. 
1.5.1 Characteristics of Duchenne Muscular Dystrophy 
Duchenne Muscular Dystrophy (DMD) is the most severe muscular 
dystrophy, characterized by widespread muscle wasting, leading to loss of 
mobility, cardiovascular and respiratory failure, and finally death. DMD is an X-
linked recessive muscular disorder with one of the highest mutation rates, 
affecting1 in 3500 male births (Blake et al., 2002). DMD patients are usually 
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bound to wheelchairs by 12 years age and died of respiratory failure in their early 
twenties. DMD is caused by mutations in the Dystrophin gene which is regarded 
as the largest in the human genome, containing 2.6 million bp DNA and 79 exons. 
It was estimated that around 60% mutations are the major frame-shift errors in 
the genome due to insertions and deletions while around 40% are due to point 
mutations and minor genome rearrangements (Hoffman and Dressman, 2001).  
During muscle contraction, dystrophin can provide a structural link 
between the cytoskeleton and the extracullular matrix by binding to the actin with 
the amino-terminus as well as to the sarcolemma with the carboxyl-terminus 
through Dystrophin Associated Protein Complex (DAPC) (Brenman et al., 1996; 
Ibraghimov-Beskrovnaya et al., 1992; Rybakova et al., 2000). To form the 
complex, dytrophin first binds to the transmembrane β-dystroglycan together with 
α-dystroglycan, which constitutes the dystroglycan subcomplex. Also, four 
isoforms of sarcoglycans can complex with sarcospan to form the sarcoglycan 
subcomplex. Additionally, two cytoplasmic components, dystrobrevins and 
syntrophins, can be anchored to the carboxyl terminus of dystrophin. Of note, 
syntrophins can interact with nitric oxide synthase (NOS) (Adams et al., 2001; 
Ibraghimov-Beskrovnaya et al., 1992), which can regulate oxidative stress 
through NO production, and the recruitment of NOS to the sarcolemma is largely 
dependent on dystrophin (Brenman et al., 1995; Chang et al., 1996). In summary, 




1.5.2 Pathophysiology of Duchenne Muscular Dystrophy 
In DMD, the absence of dystrophin renders the muscle membrane fragile 
to normal contraction. The disruption of membrane initiates a series of 
degeneration events as well as cellular protective responses. Currently, several 
pathophysiological perspectives have been investigated, including membrane 
fragility, impaired calcium homeostasis, and free radical damages. A 
comprehensive understanding of the pathophysiology underlying the deficits due 
to the absence of dystrophin will facilitate in developing new approaches for the 
treatment of Duchenne muscular dystrophy. 
1.5.2.1 Membrane Fragility  
Membrane fragility in DMD patients has been corroborated by multiple 
lines of evidence. It was demonstrated that myofibers in DMD patients 
accumulate various non-muscle proteins, indicative of membrane permeability. 
Consistent with this observation, several muscle-specific proteins and 
microRNAs, have been detected in the serum of DMD patients (Mizuno et al., 
2011; Percy et al., 1979). These results can be supported by electron microscopy 
observation of membrane lesion in the DMD muscles (Mokri and Engel, 1975). 
To make matters worse, the compromised integrity of the sarcolemma 
deteriorates under sustained exercise, especially eccentric contraction. 
Sustained exercises can cause lesion of myofiber membrane, which could be 
detected by the incorporation of Evans Blue, a dye developed for detection of 
muscle membrane permeability (Hamer et al., 2002). It was found that dystrophic 
muscles had tendency to incorporate more Evans Blue compared to WT controls 
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under sustained exercise (Straub et al., 1997). Notably, eccentric contraction 
represents the muscle contraction to the maximal length, which exerts significant 
mechanical stress on the sarcolemma. With the eccentric contraction, the ability 
of maintaining sarcolemma integrity in DMD patients is drastically reduced 
(Petrof et al., 1993). Therefore, the membrane fragility under mechanical stress 
contributes to the pathology of DMD, which suggests that physical therapy may 
be mandatory while excessive activity can be harmful to stabilize muscle 
condition in DMD patients. 
1.5.2.2 Impaired Calcium Homeostasis  
Calcium homeostasis is essential for a variety of muscle functions. Loss of 
calcium balance leads to dysfunctional muscles in various muscle diseases, 
including Duchenne muscular dystrophy. Indeed, impaired calcium homeostasis 
could be a signature event in the onset of muscular dystrophy as calcium influx 
was sufficient to induce dystrophic phenotype (Millay et al., 2009).  
The approaches by which extracellular calcium enters the muscle cells 
have not been fully clarified. It was speculated that extracellular calcium enters 
muscle fibers simply through disrupted membrane. However, multiple lines of 
evidence demonstrated that extracellular calcium entered the dystrophic muscles 
by specific channels (Alderton and Steinhardt, 2000; Franco and Lansman, 1990; 
Matsumura et al., 2011; Yeung et al., 2005). These channels have been detected 
with altered expression levels in dystrophic muscles. More relevantly, over-
expression of these channels could result in the cardiomyopathy, which further 
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suggests that these channels have pathological implication in muscular 
dystrophy (Iwata et al., 2003; Millay et al., 2009).  
The calcium homeostasis was not promptly destroyed upon membrane 
disruption. Indeed, given that muscle fibers have strong capability to balance the 
calcium concentration, the calcium homeostasis can be maintained within a short 
period. With the influx advances, high amount of extracellular calcium inevitably 
subverts the muscle’s capacity of maintaining calcium concentration and 
subsequently activates a number of calcium-dependent proteases. In particular, 
calpains can be activated by the calcium influx and play paramount roles in the 
degradation of muscle membrane protein, which further induces muscle necrosis. 
The pathophysiology of calcium influx has shed light on new strategy to improve 
muscle dystrophic phenotype. As such, some progress has been made to 
improve dystrophic phenotype by means of introducing the blockers of calcium 
channels and inhibitors of calcium-dependent proteases (Bonuccelli et al., 2003; 
Iwata et al., 2009; Yeung et al., 2005). Further attempts should be focused on 
investigating the detailed mechanism how calcium influx occurs during the onset 
of dystrophic phenotype. 
1.5.2.3 Free Radical Damage 
Free radical damage, also referred as oxidative stress, has been 
extensively investigated in various pathological conditions, including muscle 
wasting and muscular dystrophies (Arthur et al., 2008; Rando, 2002). It has been 
defined as the pathological condition wherein the endogenous antioxidants have 
been overweighed by the reactive oxidant species (ROS). It has been 
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determined that dystrophin-deficient myotubes are susceptible to oxidative 
damages (Rando et al., 1998), suggesting that oxidative stress may be involved 
in the pathophysiology of muscle dystrophy.  
One of the most characterized molecules associated with oxidative stress 
is Nitric Oxide (NO), which can be generated by the neuronal nitric oxide 
synthase (nNOS). It has been shown that nNOS directly binds to the syntrophins, 
one component of DAPC, indicating that the collapse of DAPC in dystrophic 
muscles might lead to disturbance of NO generation. Indeed, the dissociation of 
DAPC results in the translocation of nNOS from plasma membrane to cytoplasm 
as well as a concomitant reduction of NO production. Conversely, ectopic 
expression of nNOS could dramatically rescue the dystrophic phenotype 
(Wehling et al., 2001). Paradoxically, NO plays dual roles in the process of 
oxidative stress, indicated by previous study showing that NO can function not 
only as a free radical reacting with superoxide but also as an antioxidant to 
relieve oxidative stress (Touboul et al., 2005). Therefore, the pathological 
implication of NO in muscular dystrophy is complicated and it needs further 
attempts for complete understanding and therapeutic manipulation. Nevertheless, 
introducing antioxidants to the dystrophic mice dramatically reduced the muscle 
degeneration (Buetler et al., 2002; Nakae et al., 2012). In summary, the free 
radical mediated muscle damage participates in the pathophysiology of muscle 
dystrophy, although the detailed mechanism needs further investigation. 
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1.5.3 Therapies of Duchenne Muscular Dystrophy 
To date, there are no effective therapies for DMD, but a number of 
therapeutic strategies have been shown to delay or ameliorate the symptoms. 
Many of these therapies are merely effective to some extent in that they may aim 
at one aspect of the DMD pathogenesis. In particular, restoring the expression of 
dystrophin has been a promising trial for DMD therapy. It has been shown that as 
low as 30% restoration of dystrophin can prevent muscle weakness (Neri et al., 
2007). However, due to the large amount of muscle mass including cardiac 
muscles and skeletal muscles, even 30% restoration has been a great challenge. 
Moreover, the restoration should be durable, which exposes another 
considerable hurdle to the therapy. Recently, significant progress has been made 
in seeking new strategies for DMD therapies, including gene therapies and cell 
therapies. Gene therapies can be performed by the traditional approach with 
direct protein replacement or the nascent methods involving manipulation of 
gene expression through modulation of transcription, post-transcriptional 
processing and translation. Cell therapies can be mediated by transplantation of 
stem cells bearing a functional Dystrophin gene, including autologous and 
allogenic transplantation depending on cell sources. The lessons from these 
therapies also shed light on the therapeutic treatment of other genetic disorders. 
1.5.3.1 Dystrophin Restoration by Viral Delivery 
Direct recovery of absent protein can be executed through viral gene 
delivery. In the past few decades, the genome information of virus and the 
mechanism of viral infection become transparent gradually, which significantly 
25 
 
relieves people’s concern in the utilization of this viral therapy. As such, viral 
gene therapy has been applied in the treatment of multiple disorders due to its 
specific advantages in the efficiency of gene delivery.  
Currently, vectors derived from adeno-associated virus (AAV) are the 
most promising vehicles for therapeutic gene delivery. It has been documented 
that AAV delivery proved effective and durable in some clinical trial 
(Vandenberghe and Auricchio, 2012). Still, this strategy faces significant 
challenges due to the immune response. Considering the large size of dystrophin, 
viral delivery of Dystrophin gene could probably evoke more intense immune 
response. Alternatively, several strategies using dystrophin fragment have been 
designed to include functional motifs to override the mutant carried in the patient, 
such as delivery of a functional fragment containing neuronal nitric oxide 
synthase (nNOS) binding sites (Lai et al., 2009).  
Another limitation of viral gene therapy is to deliver dystrophin systemically. 
Local delivery of the Dystrophin gene under muscle specific promoters has been 
successful with no observed adverse effects (Wang et al., 2012). Due to the 
complexity of body system, systemic delivery requires further investigation on the 
vector design, particularly the promoter design. Also the durability after gene 
delivery is also a limiting factor of this therapy. To date, it remains unknown how 
long the dystrophin expression can be sustained after one delivery.  
Taken together, viral gene delivery has been a promising approach but 
requires further studies to overcome immune responses essentially. 
1.5.3.2 Dystrophin Restoration by Exon Skipping 
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Exon skipping holds promise in the treatment of muscular dystrophy. This 
strategy aims to correct the out-of-frame mutation by skipping the splicing of 
mutated exons and restoring the downstream frame, which could form a 
truncated but partially functional dystrophin protein. Recently, exon skipping has 
restored the dystrophin expression to a decent level in some clinical trials. 
Technically, different types of RNaseH dependent antisense oligonucleotides 
(AON) were designed to hybridize the sequences in or around the target exons to 
block the binding of splicing regulatory proteins and consequently skip the 
splicing of the mutated exon (Cirak et al., 2011; van Deutekom et al., 2007). To 
further optimize this strategy and enhance the efficiency of treatment, several 
bottleneck issues need to be emphasized.  
First of all, the strategy is highly personalized and mutation specific, which 
means some mutated exons are easier to skip while the others are not. This is 
supported by the fact that some DMD patients can respond to the strategy 
effectively while some others have no responses (Mitrpant et al., 2009). One 
possible solution is to design multiple-exon skipping OANs, which has been 
confirmed to be feasible in principle (Aoki et al., 2012). Secondly, although AONs 
have been well tolerated with no safety issues at present (Kinali et al., 2009; van 
Deutekom et al., 2007), the long-term safety issues remain to be clarified, which 
is important especially for this life-long treatment. Next, the efficiency of AONs is 
restricted due to the poor cellular uptake, leading to variable levels of dystrophin 
restoration in skeletal and cardiac muscles. 
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Overall, although there are still several major obstacles in clinical trials, 
exon skipping has displayed promising therapeutic value in the DMD treatment. 
1.5.3.3 Utrophin Compensation  
Utrophin has been regarded as an autosomal homologue of dystrophin, 
and they share similar sequences and structures (Davies and Nowak, 2006). 
Moreover, utrophin can interact with members of DAPC and has the same 
function as dystrophin, which provides a bridge between cytoskeleton and 
extracellular matrix.  
The major difference between utrophin and dystrophin is the expression 
pattern. In detail, dystrophin can be expressed along the whole muscle fibers 
while utrophin is restricted to the neuromuscular and myotendinous junctions. It 
has been observed that utrophin is increased and expanded beyond the 
neuromuscular and myotendinous junctions in dystrophic muscles, indicative a 
compensatory effect of dystrophin loss (Kleopa et al., 2006). This is also 
supported by the phenotype of dystrophin/utrophin double knockout mice, which 
have much worse phenotypes compared to dystrophin-deficient MDX mice 
(Deconinck et al., 1997).Furthermore, multiple studies have provided compelling 
evidence that the dystrophic phenotype can be ameliorated by increasing 
utrophin in muscles through a variety of approaches, including direct up-
regulation of utrophin transcription, direct delivery of utrophin protein, and 
stabilization of endogeneous utrophin RNA or protein (Chakkalakal et al., 2008; 
Moorwood et al., 2013; Sonnemann et al., 2009; Tinsley et al., 2011).  
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In addition, utrophin has been observed to accumulate more in the slow 
oxidative muscle fibers comparing to the fast glycolytic muscle fibers. This has 
great implication since the slow oxidative muscle fibers can be more resistant to 
the dystrophic pathology in DMD patients (Webster et al., 1988). Therefore, 
promotion of slow oxidative myogenic program may be beneficial to the treatment 
of DMD. Activation of the calcineurin-NFAT (nuclear factor of activated T cells) or 
PGC1-α (peroxisome proliferator activated receptor γ coactivator 1 α) has been 
determined to promote slow oxidative program and increase the expression level 
of utrophin, which significantly improved dystrophic phenotype (Chakkalakal et al., 
2004; Ljubicic et al., 2014; Selsby et al., 2012).  
Compared to other gene therapies, utrophin compensation holds more 
significant therapeutic promise in that this strategy of increasing utrophin is 
effective irrespective of the dystrophin mutations and it can circumvent the hurdle 
of immune response in the dystrophin-based therapies. 
1.5.3.4 Stem Cell Mediated Therapies 
Cell therapies have gained intense interest for muscular dystrophy 
treatment and were carried out in the clinical trials earlier in the 1990s (Gussoni 
et al., 1999; Mendell et al., 1995).The strategy of cell therapies is to transplant 
cells bearing the functional Dystrophin gene to the dystrophic muscles. 
Theoretically, those transplanted cells could not only migrate to the injury sites 
for regeneration but also inhabit in the satellite cell niche to self-renew for future 
use. To date, multiple types of cells have been utilized for dystrophy therapies. 
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The first attempt of DMD cell therapy was to transplant myoblasts to the 
dystrophic muscles thanks to the ease of myoblast culture. This was first 
examined in MDX mice, and the results showed that transplanted myoblasts 
fused to MDX myofibers and relayed the expression of dystrophin in the 
dystrophic muscles (Partridge et al., 1989). However, myoblast transplantation in 
clinical trials failed to provide decent increase of dystrophin in DMD patients 
(Miller et al., 1997), which may be due to the low survival rate and inability to 
migrate. To improve this, multiple injections of large quantities of myoblasts were 
performed, leading to around 10% dystrophin production in the injury sites (Skuk 
et al., 2007). Still, the low efficiency of transplantation elicits researchers to seek 
other choices for cell therapies. 
Compared with myoblasts, satellite cells point to a promising candidate for 
cell therapy of muscular dystrophy in that they could enter the satellite cell niche 
to self-renew and provide a long-time treatment. Satellite cells could be purified 
based on the surface markers and transplanted to MDX mice. After 
transplantation, those satellite cells contributed to 97% fibers and significantly 
improved muscle performance (Cerletti et al., 2008), yet several hurdles of 
satellite cell mediated therapy still need to be overcome. One of them is the 
inability to migrate over long distances, which restricted satellite cell therapy to 
local injection. Another challenge may come from the lower myogenic potential of 
satellite cells, which consequently reduced the efficiency of satellite cell therapy. 
A promising direction is to transplant cells with the matrix, such as myofibers, 
which have opened new fields in tissue engineering.  
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In addition to myoblasts and satellite cells, several other types of cells also 
have been studied for cell therapies of muscular dystrophy, such as bone marrow 
derived stem cells (Ferrari et al., 1998) and mesoangioblasts (Sampaolesi et al., 
2006). Compared to myoblasts and satellite cells, these non-myogenic cells have 
advantages in the systematic delivery as they could be delivered to muscles 
through circulatory system, yet the main challenge how to increase the myogenic 
potential remains to be explored. 
1.5.4 Animal Models of Duchenne Muscular Dystrophy 
1.5.4.1 Mouse Models 
To date, several animal models have been developed to study the 
fundamental principles and test the therapeutic approaches for DMD. The MDX 
mouse is the most widely used homologous animal model. The MDX mouse 
features a premature stop codon mutation in exon 23 of the Dystrophin gene, 
leading to little or no dystrophin protein production . The MDX mouse was born 
normal until the third postnatal week when the widespread muscle necrosis was 
initiated due to the absence of dystrophin. The muscle degeneration is followed 
by extensive muscle regeneration, indicated by centrally nucleated muscle fibers 
persisting through life. The MDX mouse has been a valuable tool for DMD study 
due to the genetic background and histological features.  
However, there have been also quantities of debates on the value of the 
MDX mouse as a DMD model. The reason why so many debates arise is that the 
pathology of MDX is far more benign than that of DMD patients. In detail, the 
lifespan of MDX mouse is similar compared to the wild type mouse. The 
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cardiomyopathy and fibrosis, typical characteristics of severe dystrophic 
phenotype, do not occur until MDX mouse undergoes aging. This drawback has 
significantly limited the utilization of MDX mouse and impeded the translation to 
the human clinical trial of data gathered from MDX. To date, great efforts have 
been dedicated to improve the application of the MDX mouse by virtue of 
breeding it to the mouse with other genetic background.  
The first attempting of breeding MDX with other genetic mouse was 
performed on the nude mouse when scientists aimed to reduce the immune 
responses during myogenic transplantation. Although this breeding did decrease 
the immune rejection as expected, the nude background had predominant effects 
on the disposition of collagen, one of the major components in the formation of 
fibrotic tissues, which raised problems in the analysis of the pathogenesis of 
muscle dystrophy (Morrison et al., 2005).  
The second attempt was based on the discovery of utrophin, which is up-
regulated in the MDX mouse and can compensate for the absence of dystrophin. 
This prompted researchers to generate the dytrophin and utrophin double knock-
out mouse. Strikingly, the mouse null for the dystrophin and utrophin exhibits 
much more severe pathology compared to MDX, closely resembling the 
phenotypes in DMD patients, including decreased growth, reduced mobility, 
muscle weakness, spinal deformities, cardiomyopathy, myofibrosis and short 
lifespan. Therefore, dystrophin and utrophin double knockout mouse has been 
proposed to provide new insight into pathogenesis and an effective model to test 
therapy for the devastating disease (Deconinck et al., 1997).  
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Another attempt came from breeding MDX with telomerase null mouse 
according to the hypothesis that the much longer telomere of mouse compared to 
that of human confers almost infinite proliferative capacity to satellite cells, which 
can fuel muscle regeneration through whole life in mouse. The reduced 
proliferative potential of muscle stem cells in the double knockout mice led to 
more severe phenotype comparing to MDX alone. Thus, the milder phenotype in 
MDX compared to DMD patients could be partially attributable to longer 
telomeres. This double mutant mouse may prove useful for explaining the 
pathophysiology of DMD and testing the therapeutic intervention for DMD 
treatment (Sacco et al., 2010).  
Altogether, these modifications to the MDX genetic background add more 
biological complexity during the translation of data obtained from mouse to 
human, indicating more caution need to be taken in the application. 
1.5.4.2 Dog Models 
Another important animal model for DMD is the Golden Retriever dog 
model. In this model, there is a splice-site mutation located in exon 7 of the 
Dystrophin gene, which causes the splicing of exon 7 from dystrophin transcript. 
As a consequence, the deletion of exon 7 shifts the open reading frame and 
leads to no protein production.  
The dystrophic phenotype in this model is so severe that the mutant dogs 
die prematurely (Sharp et al., 1992). This model has been utilized primarily as a 
reference species to test therapeutic intervention before applied into clinical trial. 
However, one problem regarding Golden Retriever dystrophic dogs is that the 
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low survival rate makes it not only time-consuming but also very expensive to 
generate enough numbers for practical application. Besides, there are also 
several distinct phenotypes of muscle dystrophy between Golden Retriever 
dystrophic dogs and DMD patients due to the differences between these two 
species. For example, some Golden Retriever dystrophic dogs died soon after 
birth due to severe phenotype, which is very rare in DMD patients. Still, this 
emphasized that the species difference need to be taken into consideration when 
applying data gathered from animal model to human beings. 
1.6 Signaling Pathways in Postnatal Myogenesis 
Muscle regeneration involves a series of orchestrated events that require 
extensive communication of multiple signaling pathways and transcriptional 
factors during the satellite cell activation and myoblast proliferation/differentiation 
as well as myotube formation. To name a few, two classical developmental 
signaling pathway, Wnt and Notch, has been corroborated to play pivotal roles in 
the myogenic response during muscle regeneration. 
1.6.1 Wnt Signaling Pathway  
The canonical Wnt activation requires the binding of extracellular Wnt 
family glycoproteins with Frizzled receptors and LPR (low-density lipoprotein 
receptor-related protein). This interaction can promote the phosphorylation of 
Disheveled, which can inhibit GSK3-β activity (GSK3-β phosphorylated at 
tyrosine 206) (Yuan et al., 1999). In the cytoplasm, GSK3-β and β-catenin can 
form the complex together with Axin and adenomatous polyposis coli (APC), in 
which the β–catenin can be phosphorylated by GSK3-β and further degraded by 
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proteasome. The inhibition of GSK3-β by phosphorylated Disheveled stabilizes 
β–catenin and allows β–catenin to enter the nucleus and interact with TCF/LEF 
transcriptional factors to regulate expression of target genes, including MyoD and 
myogenin (Church and Francis-West, 2002; Ridgeway et al., 2000) (Figure 1.1). 
Wnt signaling pathway regulates a series of biological processes, 
including cell morphology, cell adhesion, cell proliferation and cell fate 
determination. Because all these processes are highly active in skeletal muscle 
regeneration, it is plausible to assume that Wnt signaling pathway plays a key 
role in muscle repair. Indeed, mRNA transcripts of Wnt5a, 5b, 7a, and 7b are 
elevated at 4 days post cardiotoxin-induced injury (Polesskaya et al., 2003). 
Emerging evidences have shown how Wnt is involved in the postnatal 
myogenesis during muscle regeneration. However, the results were controversial 
between different research groups. Rando group determined that Wnt can 
promote myogenic differentiation only in the late stage of myogenesis (Brack et 
al., 2008). In contrast, Zammit group suggested that Wnt can promote self-
renewal and inhibit myogenic differentiation by over-expression and knockdown 
of β-catenin in single fiber culture (Perez-Ruiz et al., 2008). Taken together, Wnt 
signaling pathway does have regulatory effects on postnatal myogenesis during 
muscle regeneration. However, further studies should be conducted to 
investigate the detailed mechanism. 
1.6.2 Notch Signaling Pathway  
Activation of Notch signaling pathway require the binding of ligands (Dll1, 
3 and Jag1, 2 in mice) to Notch transmembrane receptors (Notch1-4 in mice). 
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Consequently, the binding induces the enzymatic cleavage of Notch receptors by 
metalloproteases and γ-secretases and then release the active truncated form of 
Notch receptors, named as Notch intracellular domain (NICD). Subsequently, 
NICD translocates from the cytoplasma to the nucleus, wherein NICD can 
interact with the CSL transcriptional repressors (CBF1/RBP-J, Suppressor of 
Hairless, and Lag-1) and convert them to transcriptional activators. The complex 
of NICD and CSL activates the expression of target genes, including Hes and 
Hey family genes (Artavanis-Tsakonas et al., 1999) (Figure 1.2). 
During the myogenesis, Notch signaling pathway plays critical roles in 
mediating the communication between cells due to their transmembrane location. 
Notch receptors including Notch 1, Notch 2 and Notch 3 are all expressed 
abundantly in satellite cells (Kitamoto and Hanaoka, 2010). Upon muscle injury, 
the expression levels of the Notch 1 receptor together with the Notch ligand Delta 
1 are both elevated on satellite cells and their neighbor muscle fibers (Conboy 
and Rando, 2002), which promotes the proliferation of satellite cells and inhibit 
the myogenic terminal differentiation. Inhibition of Notch by Notch antagonist or 
γ-secretase inhibitors leads to decreased proliferation and premature myogenic 
differentiation. Due to the lack of myoblast required for muscle regeneration, the 
inhibition of Notch deteriorates muscle repair (Kitzmann et al., 2006). Reversely, 
activated NICD can directly regulate Pax7 to promote myoblast proliferation and 
inhibit myogenic differentiation. As a consequence, constitutive activation of 
Notch signaling pathway also spoils muscle regeneration (Wen et al., 2012). 
Based on the active participation in muscle regeneration, Notch has provided 
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promising avenues for the treatment of muscle diseases. However, extreme 
caution should be given to balance its function in myoblast proliferation and 
differentiation. 
1.6.3 Interplay between Wnt and Notch Signaling Pathways  
It is worthy to mention that Wnt and Notch can interplay with each other 
during muscle regeneration. In the early stage of myogenesis, Notch can 
promote myoblast proliferation and inhibit precocious differentiation. As 
myogenesis proceeds, Notch inactivation is necessary for myogenic terminal 
differentiation. It has been demonstrated that the activation of Wnt pathway plays 
antagonizing effects to Notch to facilitate the terminal differentiation. This is 
supported that inactivation of Notch signaling pathway is related to the 
dephosphorylation of GSK3-β at the tyrosine 216 site, which is important for the 
stabilization of β–catenin and Wnt activation (Conboy and Rando, 2002; Hagen 
et al., 2002). Consequently, at day one post muscle injury, when myoblasts 
proliferate extensively, Notch activity is high and Wnt activity is weak. While at 
day four post injury, myoblasts are ready to enter the terminal differentiation 
phase, in which Notch activity decreases and Wnt activity increases (Brack et al., 
2008). Of note, it has been well documented that GSK3-β can directly bind to the 
NICD and regulate Notch target gene expression (Espinosa et al., 2003; Foltz et 
al., 2002). Thus it appears plausible to conclude that GSK3-β function as a 
bridge to connect Wnt and Notch signaling pathways. Therapeutic intervention of 
the balance between Wnt and Notch pathways through GSK3-β would be 
beneficial for cell fate decision during muscle regeneration. 
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1.7 Brain Expressed X-linked Protein 1 (Bex1)  
1.7.1 Brain Expressed X-linked Gene Family  
Bex1 belongs to the Bex gene family, which is relatively small but may 
play essential roles in the development and function in mammals. It was reported 
that Bex family was highly expressed at rat embryonic day 10 of development 
during ventral mesencephalon development, suggesting the role of Bex family in 
the dopamine neuron differentiation (Alvarez et al., 2005). To date, six members 
of the Bex family have been discovered, including Bex1Bex1Bex1, Bex2, Bex3, 
Bex4, Bex5 and Bex6. Except Bex6, which is in chromosome 16, the other five 
members are located in the X chromosome with tandemly arrangement. In detail, 
Bex5, Bex1Bex1Bex1 and Bex2 are located in the negative strand while Bex3 
and Bex4 in the positive strand tandemly (Zhang, 2008). In addition, the gene 
structures of the whole family are well conserved. All of them contain three exons 
while the first two exons are not translated.  
All the six members of Bex family have been characterized in term of their 
sequences and expression pattern in human, mice, and rats (Figure 1.3). For 
instance, the amino acid sequences of human Bex1 and Bex2 are almost 
identical (85% identity) and both of them are highly expressed in central nervous 
system, including pituitary, cerebellum, and temporal lobe (Alvarez et al., 2005). 
Bex3, also named as pHGR74 or NADE, has been determined to interact with 
low-affinity neurotrophin receptor (p75NTR) to mediate apoptosis signaling 
(Mukai et al., 2000). Also, it has been demonstrated that Bex3 is abundantly 
expressed in the human ovarian granulose cells (Rapp et al., 1990). Although 
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Bex3 is only 30% identical to Bex1 or Bex2 in their sequences, they still share 
some major function domains, indicating they may be involved in similar 
biological process. Indeed, Bex1, Bex2 and Bex3 are all expressed in the 
olfactory system (Behrens et al., 2003). In addition, Bex4 and Bex5 share 54% 
and 56% sequence identity with Bex3, respectively. And both of them are very 
similar in sequences and are highly expressed in brain. Besides, Bex4 is highly 
expressed in heart, skeletal muscle and liver, which may indicate that it is 
associated with high energy consumption. Compared to Bex4, Bex5 is more 
widely expressed (Alvarez et al., 2005). As a novel member of Bex family, Bex6 
is the only one which is not expressed in human. Also Bex6 is not located in X 
chromosome but chromosome 16 in mouse, which suggests a distant 
relationship with other members. As for the subcellular localization, the six 
members of Bex family vary greatly. Bex1 is more confined to the nucleus while 
Bex3, Bex5 and Bex6 are expressed in cytoplasm. Bex2 and Bex4 can be 
expressed in both nucleus and cytoplasm (Alvarez et al., 2005). Taken together, 
the six members of Bex family are highly homologous but different in the 
expression pattern as well as the subcellular localization. 
1.7.2 Bex1 Structure and Expression Pattern  
Bex1 gene is located in the 53.77cM on X chromosome in mouse, which 
corresponds to the Xq22 region on human X chromosome. In mouse, the gene 
consists of three exons which span around 1.5kb of genomic DNA and the size of 
mRNA transcript is around 800bp. There are more transcripts expressed from the 
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maternally inherited allele compared with the paternally inherited allele, indicating 
an imprinted expression pattern (Brown and Kay, 1999). Bex1 protein has 128 
amino acids, including a nuclear localization signal, a histidine-rich sequence 
close to the carboxyl terminal and a carboxyl terminal CLMP motif (Behrens et al., 
2003; Brown and Kay, 1999).   
In mouse, Bex1 is highly expressed in brain with low levels in lung and 
gonads (Brown and Kay, 1999). While in human, northern blot analysis revealed 
that the approximately 1kb mRNA transcript is expressed abundantly in brain, 
pancreas, ovary and testis while at low levels in heart, placenta, liver, kidney, 
thymus, spleen, prostate, small intestine, adrenal gland, thyroid, and spinal cord. 
There is no expression in lung, stomach, bone marrow, and skeletal muscles 
(Yang et al., 2002). Also, Bex1 was identified with an up-regulation after 
fertilization (Williams et al., 2002), indicating that Bex1 may play roles in 
embryonic development. Altogether, although the expression pattern was well 
characterized, the detailed function of Bex1 remains to be clarified, especially in 
some specific tissues.  
1.7.3 Bex1 Functions  
Bex1 was first identified with reduced expression in the teratocarcinoma 
cell line after treatment of retinoic acid and characterized in the analysis of 
imprinted genes between parthenogenetic and normal blastocysts (Brown and 
Kay, 1999; Faria et al., 1998). Multiple studies have been performed afterwards 
to explore the function of Bex1 in many biological processes. Bex family 
members are well conserved and the amino acid sequence of Bex1 has 87% 
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identity with Bex2 but lower similarity to other members (30% identity with Bex3, 
25% identity with Bex4, 20% identity with Bex5, 18% identity with Bex6). Notably, 
some functional domains among the Bex family members are well conserved, 
suggesting that these Bex proteins may share the same implication in term of 
biological activity. For instance, researchers first found that Bex3 could bind 
p75NTR directly to mediate the neurotrophin signaling pathway (Mukai et al., 
2000). Due to the similarity of sequences implicated in the p75NTR binding 
between Bex1 and Bex3, it has been proposed and finally confirmed that Bex1 
can also bind to p75NTR to play roles in neurotrophin signaling pathway (Vilar et 
al., 2006). To date, the functions of Bex1 has been associated with 
tumorigenesis, p75NTR mediated cell cycle regulation, neuron regeneration, and 
muscle regeneration. However, the molecular mechanism behind Bex1 
regulation has remained to be clarified.  
1.7.3.1 Bex1 is A Tumor Suppressor. 
To date, most Bex1-related studies focus on its contribution in the 
formation of various tumors, including pediatric intracranial ependymoma 
(Karakoula et al., 2014), oral squamous cell carcinoma (Lee et al., 2013), salivary 
gland adenoid cystic carcinoma (Shao et al., 2011), malignant glioma (Foltz et al., 
2006) and so forth. Based on these studies, Bex1 has been determined as a 
tumor suppressor. Inactivation of tumor suppressor genes, together with 
overexpression of oncogenes, has been regarded as the dominant driving force 
of tumorigenesis. Inactivation of tumor suppressor genes can be attributable to 
multiple reasons. Epigenetic regulation is one of the reasons and has drawn 
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intense interest in the field in the past decades. The most common epigenetic 
mechanism implicated in the inactivation of tumor suppressor genes includes 
promoter hypermethylation and histone deacetylation. In those aforementioned 
Bex1-related tumors, Bex1 was markedly silenced in the tumor specimens by 
extensive promoter hypermethylation. Furthermore, Bex1 over-expression can 
dramatically inhibit cell proliferation and colony formation.  
Besides its role of tumor suppressor in cancer, Bex1 is also essential to 
understanding the acquisition of chemoresistance in the progression of multiple 
tumors, such as breast cancer and leukemic cells. Chemotherapy can induce cell 
apoptosis and has been applied to the treatment of various cancers. Although an 
expanding amount of chemotherapy reagents have been developed in the past 
decades, chemoresistance of tumor cells still poses a significant challenge in 
cancer treatment. The mechanism of chemoresistance has been under intense 
investigation. Bex1 down-regulation in cancer cells is a novel mechanism by 
which cancer cells can obtain the chemoresistance and escaped  apoptosis. In 
contrast, ectopic expression of Bex1 can sensitize cell to apoptosis induced by 
chemotherapy (Foltz et al., 2006). It has been recently demonstrated that Bex1 
can promote imatinib-induced apoptosis through interacting with BCL-2 and 
suppressing the formation of anti-apoptotic complex Bcl-2/BAX (Xiao et al., 2014). 
Taken together, Bex1 functions as a tumor suppressor and can be a potential 





1.7.3.2 Bex1 Regulates Cell Cycle through p75NTR. 
Understanding the involvement of Bex1 in tumor progression can be 
associated with the function of Bex1 in cell cycles. It has been found that Bex1 
can prevent normal neuron cell cycling and inhibition of Bex1 in neuron cells can 
lead to sustained cell proliferation under the condition of growth arrest. Further 
studies have confirmed that Bex1 regulates cell cycle by interacting with p75NTR 
to participate in neurotrophin signaling pathway (Vilar et al., 2006). 
Neurotrophin signaling pathway has been characterized to regulate cell 
survival, growth and differentiation in a variety of neuronal subpopulations. Two 
types of receptors are involved in the neurotrophin signaling pathway. One is the 
high affinity receptors (Trk tyrosine kinases) while the other is the low affinity 
receptors (the p75 neurotrophin receptor, p75NTR). It has been determined that 
two Bex family members, Bex1 and Bex3, can interact with p75NTR to initiate 
signal transduction (Mukai et al., 2000; Vilar et al., 2006).The binding of 
neurotrophin to p75NTR can lead to multiple physiological consequences in the 
neuron system, varying from cell apoptosis to neurite survival and even 
outgrowth. This is supported by the observation that p75NTR knockout mice 
have markedly less sensory neurons but normal motor neurons in dorsal root 
ganglia as well as dramatically increased cholinergic neurons in basal forebrain 
(Niklison-Chirou et al., 2013). These multifaceted functions of p75NTR signaling 
pathway reflects that other factors may be involved in the regulation process.  
Furthermore, due to lack of intrinsic catalytic ability of p75NTR receptor, 
the signaling pathway is largely dependent on the p75NTR-interacting molecules. 
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Because of these different mediators, p75NTR can exert its multiple effects on 
cellular activity. For example, p75NTR can inhibit cell mitosis through interacting 
with SC1 and promote neurite outgrowth through activating RhoA as well as 
induce cell death through NRAGE (Chittka et al., 2004; Salehi et al., 2000; Taylor 
et al., 2001). However, the detailed mechanism how the interaction between 
p75NTR and interactors with or without catalytic capability mediates downstream 
signaling pathway and cellular response needs to be investigated specifically 
based on cellular context. 
Vilar et al. has demonstrated that Bex1 and p75NTR share essentially 
indistinguishable expression pattern in the nervous system as well as vascular 
and mesenchymal structures during embryonic development. They continued to 
confirm that Bex1 can directly interact with p75NTR intracellular domain (Vilar et 
al., 2006). Considering the regulation of p75NTR signaling on the cell cycle and 
cell apoptosis, Bex1 expression levels may have great implication in the 
intracellular machinery controlling cell survival, proliferation and differentiation. 
1.7.3.3 Bex1 Regulates Neuron Regeneration. 
Regeneration in neuron system could be complicated partially due to the 
different regeneration capacity based on different location. In detail, axons in 
peripheral neuron system can be repaired after injury while axons in central 
neuron system do not preserve any regeneration capability. This difference can 
be attributable to both intrinsic and extrinsic factors. Axons in central neuron 
system are intrinsically lack of ability of regrowth. Besides, a variety of extrinsic 
factors in the central neuron system can be released to inhibit the regrowth, such 
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as myelin-associated glycoprotein (MAG) (McKerracher et al., 1994; Richardson 
et al., 1980). In contrast, the injured axons in peripheral neuron system can not 
only induce the intrinsic capacity of neuron regrowth but also stimulate multiple 
extrinsic regeneration-related gene expression to overcome the blockage of 
inhibitory factors .  
Bex1 has been identified as one of the extrinsic regeneration genes, which 
is indicated by the observation that the expression level of Bex1 was elevated 
after axon injury as well as that Bex1 expression is consistent with several 
established regeneration genes in multiple mouse models. Also Bex1 knockout 
mice are deficient in axon regeneration after sciatic-nerve injury, a well-
established model for studying neuron regeneration. Furthermore, Bex1 can 
counteract the inhibition of inhibitory factors during axon regeneration in that the 
motor neuron expressing Bex1 can grow longer axon than wild type in the 
presence of MAG. Therefore, Bex1 can be categorized as a regeneration gene 
during peripheral neuron repair (Khazaei et al., 2010).  
To date, the mechanism of Bex1 involvement in the axon regeneration at 
the molecular level remains elusive. It was hypothesized that the interaction 
between Bex1 and p75NTR signaling pathway may be conducive to 
understanding the mechanism as p75NTR signaling pathway can regulate 
neuron cell growth and differentiation as well as p75NTR also interacts with MAG 
(Dubreuil et al., 2003; Robak et al., 2009; Vilar et al., 2006). Future endeavors 




1.7.3.4 Bex1 Regulates Muscle Regeneration. 
The relevance of Bex1 in muscle regeneration was discovered in a 
microarray aimed to identify a panel of genes with altered expression in CTX 
induced muscle injury, a well-established model for muscle regeneration (Yan et 
al., 2003). Consistently, the expression level of Bex1 was dysregulated in MDX 
mice (Turk et al., 2005), which undergo progressive muscle degeneration and 
regeneration. Bex1 knockout mice have prolonged proliferation and delayed 
differentiation kinetics. In addition, both cell cycle inhibitor genes and myogenic 
differentiation marker myogenin were down-regulated compared to regenerating 
wild type muscles (Koo et al., 2007).  
It has been suggested that Bex1 regulates muscle regeneration through  
interacting with calmodulin (CaM) (Koo et al., 2007). And Bex1 and CaM co-
localize in myogenic cells during muscle regeneration (Koo, 2010). CaM can bind 
calcium to activate calcium dependent kinases and initiate calcium signaling 
pathway. Due to the indispensable role of calcium in myogenesis, it is logical to 
hypothesize that the interaction between Bex1 and CaM contributes to muscle 
regeneration. Moreover, one can speculate that the interaction between Bex1 
and p75NTR also contributes to the regeneration of skeletal muscles since 
p75NTR is also highly expressed in myogenic cells (Lomen-Hoerth and Shooter, 
1995; Yamamoto et al., 1996). Besides, given that muscle regeneration is a 
complicated process which requires a series of coordinated responses from 
surrounding cells, this hypothesis is also supported by the observation that 
neurotrophins are secreted by various cells in the developing limb bud 
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(Henderson et al., 1993; Ip et al., 2001). Furthermore, analysis of their 
expression pattern during embryonic development shows that Bex1 and p75NTR 
can be concomitantly expressed in the somatic mesenchyme and heart (Cotrina 
et al., 2000; von Schack et al., 2001), suggesting that Bex1 could interact with 
neurotrophin signaling pathway in muscle regeneration. However, detailed 
mechanism underlying Bex1’s function in satellite cells and muscle regeneration 
remains to be clarified. 
1.8 Rationale and Objectives 
Under normal conditions, skeletal muscles are very stable with little 
myonuclei turnover. However, skeletal muscles are susceptible to injury, which 
may lead to mass loss and functional deficiency. Skeletal muscles have a 
remarkable capacity to initiate the repairing process, muscle regeneration, to 
prevent further muscle loss and maintain normal muscle function. The overall aim 
of this dissertation is to study muscle regeneration process at the cellular and 
molecular level. In detail, two projects are included in this dissertation. The first 
one is to investigate how Notch signaling pathway regulates satellite cells 
behavior and further affects skeletal muscle regeneration in MDX mice. The 
second one is to explore the role of Bex1 in the myogenesis as well as muscle 
regeneration. This Chapter mainly reviews the current knowledge related to 
these two objectives. Satellite cells, which play an essential role in muscle 
regeneration, are emphasized. Importantly, it is worthy reviewing the knowledge 
related to MDX, the widely used mouse model for Duchenne muscle dystrophy, 
which is characterized by progressive muscle degeneration and regeneration. 
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Besides, a number of signaling pathways and transcriptional factors have been 
demonstrated to regulate muscle regeneration. In particular, Notch signaling 
pathway and Bex1 are discussed in more details to provide a comprehensive 
understanding in the follow-up experiments. 
Muscle regeneration is a perfect model to study skeletal muscle stem cell 
biology in that it can facilitate exploring not only basic mechanisms of muscle 
development but also the therapeutic potentials of muscle stem cells. Therefore, 
unraveling the regulatory network behind muscle regeneration has drawn intense 
research attention in the field. To date, great progress has been made in 
understanding muscle regeneration, yet there are many unanswered question 
and unexplored areas. With this notion in mind, the roles of Notch signaling 
pathway and Bex1 gene in muscle regeneration were investigated in this 
dissertation. Notch signaling pathway plays multifaceted roles in the myogenesis. 
In particular, Notch can promote the self-renewal capacity of satellite cells, the 
predominant cellular source for muscle regeneration. Whether promoting satellite 
cell self-renewal contributes to muscle regeneration is an intriguing question. If 
so, enhancing satellite cell self-renewal may lead to improved muscle function in 
various degenerative and congenital muscle diseases, such as Duchenne 
muscular dystrophy. Next, Bex1 has been implicated in regeneration of motor 
neuron and skeletal muscles. However, the role of Bex1 in myogenic satellite 
cells and the underlying mechanisms remain to be elucidated. Several findings 
related to the function of other Bex family members may open new perspectives 
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Figure 1.2  A Diagram of the 
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Figure 1.3  Alignment of the 
Shown are the amino acid sequences comparison of human Bex1, Bex2, Bex3, 
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CHAPTER 2. NOTCH SIGNALING DEFICIENCY UNDERLIES AGE-
DEPENDENT DEPLETION OF SATELLITE CELLS IN MUSCULAR 
DYSTROPHY 
Previously published by Disease Models and Mechanisms in Aug 2014 
 
2.1 Abstract 
Duchenne Muscular Dystrophy (DMD) is a devastating disease 
characterized by muscle wasting, loss of mobility and early death. Satellite cells 
are muscle-resident stem cells responsible for the repair and regeneration of 
damaged muscles. One pathological feature of DMD is the progressive depletion 
of satellite cells, leading to the failure of muscle repair. Here I attempted to 
explore the molecular mechanisms underlying satellite cell ablation in the 
Dystrophin mutant MDX mouse, a well-established model for DMD. Initial muscle 
degeneration activates satellite cells, resulting in increased satellite cell number 
in young MDX mice. This is followed by rapid loss of satellite cells with age due 
to reduced self-renewal ability of MDX satellite cells. In addition, satellite cell 
composition is altered even in young MDX mice, with significant reductions in the 
abundance of non-committed Pax7+/Myf5- satellite cells. Using a Notch-reporter 
mouse, I found that the MDX satellite cells have reduced activation of Notch 
signaling, which has been shown to be necessary to maintain satellite cell
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quiescence and self-renewal. Concomitantly, the expression of Notch1, Notch3, 
Jag1, Hey1 and HeyL are reduced in the MDX primary myoblast.  Finally, I 
established a mouse model to constitutively activate Notch signaling in satellite 
cells, and show that Notch activation is sufficient to rescue the self-renewal 
deficiencies of MDX satellite cells. These results demonstrate that Notch 
signaling is essential for maintaining the satellite cell pool and its deficiency leads 
to depletion of satellite cells in DMD. 





Muscular dystrophies include a spectrum of inherited diseases leading to 
progressive muscle degeneration and dysfunction (Wallace and McNally, 2009). 
The most severe and common form of muscular dystrophy is Duchenne 
Muscular Dystrophy (DMD). DMD is a devastating recessive X-linked muscle 
degenerative disease caused by frame shift deletions, duplications, or point 
mutations in the Dystrophin (DMD) gene (Hoffman et al., 1987; Worton et al., 
1984). Dystrophin is a cytoskeletal protein that interacts with a group of 
peripheral membrane and transmembrane proteins, such as dystroglycan and 
sarcoglycan, to form the dystrophin-associated protein complex (DAPC) 
(Matsumura et al., 1994). The DAPC provides a linkage between the 
cytoskeleton and extracellular matrix of muscle fibers, and maintains the integrity 
of sarcolemma (muscle membrane) during muscle contraction (Ervasti and 
Sonnemann, 2008). Absence of Dystrophin results in the disassociation of the 
DAPC. As a consequence, the sarcolemma becomes fragile to mechanical 
damages, and normal muscle activity would result in muscle degeneration, 
chronic inflammation and fibrosis (Petrof et al., 1993). These pathological 
stimulations alter the tissue environment and compromise muscle function to 
further deteriorate the dystrophic phenotype. DMD patients typically suffer from 
rapid progression of muscle degeneration, and are eventually paralyzed and die 
in their second to third decade of life. 
Skeletal muscles have a remarkable capacity to regenerate. This capacity 
is mainly attributed to a stem cell population called satellite cells.  Satellite cells 
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are muscle-specific adult stem cells responsible for muscle regeneration in 
response to injuries . Upon a muscle injury, satellite cells, located between the 
basal lamina (i. e. the muscle extracellular matrix) and sarcolemma, are activated 
from quiescence and proliferate as myogenic precursor cells, the proliferating 
myoblasts then undergo either self-renewal and return to quiescence, or 
differentiation to form functional muscles (Anderson, 2006; Cheung and Rando, 
2013; Kuang and Rudnicki, 2008; Wagers and Conboy, 2005). In healthy 
humans, satellite cells can proliferate and repair muscle damage. However, 
unrelenting muscle degeneration in DMD puts satellite cells in a constant 
activation mode and eventually depletes the satellite cell pool, leading to the 
failure of muscle repair and accelerated disease progression (Blau et al., 1983; 
Blau et al., 1985; Heslop et al., 2000).  
Currently, there is no effective treatment for DMD patients. To date, stem cell – 
based therapeutic strategies are under intense investigations. The stem cell 
therapies mainly include delivery of exogenous muscle stem cells to boost the 
regeneration of DMD muscles, and functional enhancement of endogenous 
muscle stem cells (Bentzinger et al., 2010; Quattrocelli et al., 2010; Shi and 
Garry, 2006). However, stem cell therapies are still in their infancy and to achieve 
the full potential of these regenerative approaches, it is necessary to better 
understand the cellular and molecular mechanisms governing satellite cell 
behavior and function.  Previous studies have shown that Notch signaling 
pathway plays important roles in maintaining satellite cell quiescence as well as 
regulating proliferation and differentiation (Bjornson et al., 2012; Buas and 
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Kadesch, 2010; Conboy and Rando, 2002; Mourikis et al., 2012). Constitutive 
activation of Notch pathway promotes the self-renewal of satellite cells by up-
regulating Pax7, a key regulator of satellite cell identity (Wen et al., 2012). 
Conversely, blockage of Notch signaling in satellite cells results in muscular 
dystrophy characteristics and impairs muscle regeneration (Lin et al., 2013). 
However, whether Notch signaling is deregulated in satellite cells of dystrophic 
muscles and whether it contributes to the progression of muscle degeneration 
have not been determined.  
In this study, I aimed to address these questions using the MDX mouse 
model (Bulfield et al., 1984), which carries a mutation in the Dmd gene and thus 
has been widely used as an animal model for human DMD (Partridge, 2013). I 
discovered that MDX satellite cells exhibit defective self-renewal capacity 
associated with attenuated Notch signaling transduction. Importantly, constitutive 
activation of Notch signaling in the MDX satellite cells rescued their self-renewal 
defects. These data demonstrate that the attenuated Notch signaling in MDX 
leads to satellite cell dysfunction, and further suggest that Notch signaling 
preserves therapeutic potential to retain the self-renewal capacity in dystrophic 
muscles. 
2.3 Materials and Methods 
2.3.1 Animals  
Myf5nLacZ  mice were provided by Shahragim Tajbakhsh (Christov et al., 
2007). All other mice are available from Jackson Laboratories (ROSA26-N1ICD 
stock number 008159 and MDX stock number 001801, Pax7-CreER stock 
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number 012476, CpGFP stock number 005854). Mice were maintained in a clean 
mouse facility at Purdue University. All procedures involving animal maintenance 
and experimental use were performed according to the guidelines presented by 
Purdue University’s Animal Care and Use Committee. 
2.3.2 Muscle Injury and Regeneration  
Muscle regeneration was induced by Cardiotoxin (CTX; Sigma-Aldrich, St. 
Louis, MO) injection. Mice were first anesthetized using a ketamine-xylazine 
cocktail, and then 50ul of 10 mM CTX was injected into the Tibialis Anterior (TA) 
muscle. Muscles were harvested at 7 days post injection. 
2.3.3 Electroporation of DNA Plasmids into TA Muscles  
About 10 µl of empty pEF-BOS Neo plasmid, Jag1 plasmid, or RAMIC 
domain (NICD) plasmid were injected at a concentration of 0.5 µg/µl (in 0.9% 
NaCl) into TA muscles along the whole muscle length. Two spatula electrodes 
were then placed on each side of the muscle belly, and eight pulses (20 ms  200 
V/cm) at 1 second intervals were applied to the electrodes controlled by a BTX 
ECM 830 electroporator (Genetronics, San Diego, CA). The dosage was 
established in a preliminary study using the GFP plasmid, in which ~70% 
myofibers in the vicinity of the injection site and ~30% fibers in the whole muscle 
were GFP+ at 1 week after electroporation. Using this protocol, Jag1 or RAMIC 
was electroporated into the left TA muscles of the Cp-GFP mice, and the empty 
pEF-BOS vector was electroporated into the contralateral (right) TA as control. 
One week after electroporation, the TA muscles were harvested for assessment 
of Cp-GFP and Pax7 expression by immunohistochemistry. 
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2.3.4 Isolation and Culture of Single Fibers and Primary Myoblast  
Single myofibers were isolated from the Extensor Digitorum Longus (EDL) 
muscles after collagenase A (Sigma) digestion for 45 min to 1 hour. Suspended 
fibers were collected and cultured in horse serum-coated plates in Dulbecco’s 
modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS; 
HyClone, Logan, UT), 2% chicken embryo extract (Accurate Chemical, Westbury, 
NY), and 1% penicillin-streptomycin for 72hs.  
Primary myoblast was collected from limb skeletal muscle. These muscles 
were minced and digested with a cocktail of type I collagenase and Dispase B 
mixture. Debris was removed using filters from cells. Primary myoblast was 
cultured in 100mm collagen coated plates in the growth medium (F-10 Ham’s 
medium supplemented with 20% FBS, 4 ng/ml basic fibroblast growth factor, and 
1% penicillin-streptomycin) at 37°C, 5% CO 2. 
2.3.5 Fluorescent Activated Cell Sorting  
Cells were isolated from hindlimb muscles of 6- to 8-week-old mice. 
Erythrocytes were removed through the Red Blood Cell Lysing Buffer Hybri-Max 
(Sigma). Mononuclear cells were blocked with goat serum for 10 min and 
incubated with primary antibodies in DMEM with 2% FBS at 1–3 × 107 cell/ml for 
15 min at 4℃. Cells were briefly washed and incubated with appropriate 
secondary antibodies (1: 1000) at 4℃ for 15 min. After staining, cells were 
washed, passed through 30 µm filters (Miltenyi Biotec) and suspended at a 
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concentration of 1 ×107 cells/ml. Cells were separated on a MoFlo cytometer 
(DakoCytomation) equipped with three lasers. Sorting gates were strictly defined 
based on single antibody-stained control cells as well as the forward and SSC 
patterns of satellite cells based on preliminary tests. 
2.3.6 Cryosection  
Fresh TA muscles were embedded in optimal cutting temperature (OCT) 
compound (Sakura Finetek) and immediately frozen in dry ice-cooled isopentane. 
Muscle blocks were cut by 10um with a Leica CM 1850 cryostat instrument. The 
sections were placed on Superfrost Plus glass slides (Electron Microscopy 
Sciences). 
2.3.7 Immunostaining and Image Capture  
Muscle fibers and tissue sections were first fixed in 4% PFA and blocked 
in the blocking buffer containing PBS, 5% horse serum, 2% bovine serum 
albumin, 0.2% Triton X-100 and 0.1% sodium azide for 60mins. Then the fibers 
and sections were incubated with primary antibodies diluted in blocking buffer 
overnight at 4℃, then incubated with secondary antibodies and Hoechst diluted 
in PBS for 30 minutes at room temperature, and mounted with Dako fluorescent 
mounting media (Glostrup, Denmark). Fluorescent pictures were taken with a 
Coolsnap HQ CCD camera (Photometrics, USA) driven by IP Lab software 
(Scanalytics, USA) in a Leica DMI 6000B fluorescent microscope (Mannheim, 
Germany). As the analysis of the immunofluorescence was qualitative, identical 
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image handling and fluorescence scoring criteria were applied in all the 
experiments. 
2.3.8 Quantitative Real-time Polymerase Chain Reaction (qPCR)  
RNA was extracted and purified from wild type and MDX primary myoblast 
cell cultures using Trizol. Random hexamer primers were used for the reverse 
transcription from RNA to cDNA. qPCR was performed with a Light Cycler 480 
machine (Roche). 18s was used as housekeeping gene for normalization. For 
qPCR result analysis, 2-ΔΔct method was applied to calculate the fold change.  
2.3.9 Statistical Analysis  
The data are displayed with mean ± s.e.m. P-values were calculated by 
two-tailed Student’s t-test. P-values <0.05 were considered to be statistically 
significant. 
2.4 Results 
2.4.1 Satellite Cell number and Activity Decline with Age in MDX Mice.  
As satellite cells are necessary for postnatal muscle regeneration (Lepper 
et al., 2011; Murphy et al., 2011; Sambasivan et al., 2011), I aimed to examine 
satellite cell behavior in MDX mice whose muscles are under repetitive 
degeneration and regeneration. I first examined the abundance of satellite cells 
associated with freshly isolated myofibers from the Extensor Digitorum Longus 
(EDL) muscles of WT and MDX mice at different ages (Figure 2.1A). 
Interestingly, there were significantly more Pax7+ satellite cells per myofiber in 
the MDX than WT mice at 2-, 6- and 12-month-old (Figure 2.1B). Whereas the 
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number of WT satellite cells continually decline with age at a slow rate, the MDX 
satellite cell number initially increases from 1-month-age to 6-month-age, 
followed by rapid decline afterwards (Figure 2.1B). As the severity of muscle 
pathology starts at approximately 2 months of age in mice (Bulfield et al., 1984), 
the initial increases in satellite cell number reflect the activation of satellite cells 
due to ongoing muscle injuries. The rapid decline of satellite cell number starting 
at 6 months of age suggests that the MDX satellite cells are unable to maintain a 
proper balance of proliferation, self-renewal and differentiation.  
I further examined the proliferative activity of satellite cells in vivo and in 
vitro. In response to cardiotoxin (CTX)-induced muscle degeneration, satellite 
cells are activated and proliferate, then fuse to repair the injury. At Day 5 post 
CTX injection into TA muscles, the number of satellite cells per myofiber 
increased in both WT and MDX mice at 1-6 months of age (Figure 2.1C). 
However, the CTX-stimulated fold increases of satellite cells rapidly decreased 
with age in the MDX, but not in the WT mice (Figure 2.1D). These results 
indicate severe age-dependent deficiencies in the activation and/or proliferation 
of satellite cells in the MDX mice. I also cultured satellite cells while they are still 
attached on their host myofibers that were singly dissociated from 12 and 24-
month-old mice (Figure 2.1E). After 72h in culture, the WT satellite cells 
proliferated and formed clusters of cells, but the MDX satellite cells in both 12 
and 24-month-old mice failed to form cell clusters (Figure 2.1F). This observation 
confirms that satellite cell activity declines dramatically in aged MDX mice.  
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2.4.2 MDX Satellite Cells Have Reduced Self-renewal Capacity.  
Self-renewal is a defining feature of all stem cells and necessary for 
maintaining the homeostasis of stem cells. I hypothesized that the age-
dependent depletion of satellite cells in the MDX mice is due to a reduced self-
renewal capacity. To test the hypothesis, I established the Myf5nLacZ/MDX mice 
by breeding MDX mice with Myf5nLacZ mice that marks Myf5-expressing cells by 
nuclear localized β-galactosidase (Christov et al., 2007). Previous studies have 
shown that Pax7+Myf5- satellite cells give rise to Pax7+Myf5+ satellite cells during 
myogenic commitment, and the Pax7+Myf5- cells have higher self-renewal 
capacity (Kuang et al., 2007).  I isolated EDL myofibers from WT (Myf5+/+/MDX) 
and MDX (Myf5nLacZ/+/MDX) mice that were injected with CTX to assure satellite 
cells in both WT and MDX mice were in the same activated state. Satellite cells 
were then labeled with antibodies to Pax7 and β-gal (Figure 2.2A). In the 
absence of CTX-induced injury, similar proportions of Pax7+Myf5- (β-gal-) satellite 
cells were found between WT and MDX mice, at both 2 and 6 months of age 
(Figure 2.2B). After CTX-induced muscle injury, the abundance of Pax7+Myf5- 
satellite cells was reduced in the MDX mice at both 2- and 6-month-old (Figure 
2.2C). Furthermore, the CTX-induced fold change of Pax7+Myf5- satellite cells 
was decreased in MDX compared to WT mice at both 2 and 6 months of age 
(Figure 2.2D). These in vivo data demonstrate that there is a self-renewal defect 
in MDX satellite cells. 
I further examined satellite cell self-renewal using a well-established 
paradigm involving culture of dissociated myofibers (Halevy et al., 2004; Olguin 
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and Olwin, 2004; Zammit et al., 2004). After culture, the  self-renewal, 
proliferation and differentiation progenies can be distinguished as Pax7+MyoD-, 
Pax7+MyoD+ and Pax7-MyoD+, respectively, based on their Pax7 and MyoD 
expression pattern (Figure 2.2E). Quantitative analysis indicates that the 
percentage of Pax7+MyoD- (self-renewal) cells was drastically decreased in MDX 
myofiber cutlures (37% in WT vs 20% in MDX), while the percentage of 
Pax7+MyoD+ (proliferating) cells was increased in the MDX and the percentage 
of Pax7-MyoD+ (differentiating) cells was not  different between WT and MDX 
(Figure 2.2F). Moreover, the expression of MyoG, a terminal differentiation 
marker of myogenesis, was examined after 72 hours myofiber culture (Figure 
2.2G). Quantitative analysis revealed that the ratio of MyoG+/MyoD+ cells was 
elavated in MDX at both 2 and 6 months of age (Figure 2.2H), suggesting that 
MDX satellite cells have a higher tendency for terminal differentiation. 
Collectively, these cell culture data are consistent with the notion that the MDX 
satellite cells have reduced self-renewal capacity. 
2.4.3 The Notch Signaling Pathway Is Perturbed in MDX Satellite Cells  
To understand the molecular mechanism underlying the reduced self-
renewal capacity in the MDX satellite cells, I investigated the Notch signaling 
pathway, which has been shown to mediate satellite cell self-renwal and 
quiescence (Vasyutina et al., 2007). I detected that the expression of genes 
related to Notch signaling pathway was reduced dramatically at both young 
(Figure 2.3A) and old (Figure 2.3B) MDX muscles. Strikingly, the reduction was 
much more robust in the old (12-month-old) MDX mice (Figure 2.3B compared 
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to Figure 2.3A). The reduced expression of Notch receptors, ligands and target 
genes in MDX muscles indicate an impairment of Notch signaling transduction.  
To directly visualize the activation status of Notch signaling in satellite 
cells, I used the Cp-GFP reporter mouse (Mizutani et al., 2007). In this transgenic 
mouse, GFP expression is driven by 4 tandem repeats of DNA sequence 
recognized by Rbpjk, the nuclear mediator of Notch signaling. When Notch is not 
activated, Rbpjk binds to transcriptional repressors which suppress GFP 
expression. Upon activation (ligand binding), Notch intracellular domain (NICD) 
would detach and translocate to the nucleus, where it replaces the transcriptional 
repressors on Rbpjk and activates GFP expression. To establish the utility of this 
model in satellite cells, single myofibers were isolated from the Cp-GFP mice and 
GFP and Pax7 expression was examined (Figure 2.3C-a). A fraction (~17%) of 
Pax7+ satellite cells was GFP+ (Figure 2.3C-b). Next, fluorescent activated cell 
sorting (FACS) was used to isolate GFP+ and GFP- satellite cells using α7-
Integrin (Int-α7) as a positive selection marker for satellite cells (Figure 2.3C-c). 
Analysis of FACS-purified satellite cells indicates that 8% freshly sorting satellite 
cells (Lin-Int-α7+) were also GFP+ (Figure 2.3C-d). Importantly, the FACS-
purified GFP+ satellite cells expressed higher levels of Hes1 (Figure 2.3C-e), a 
canonical target of Notch signaling pathway. To further examine if the Cp-GFP 
reporter responds to Notch activation in vivo, the DNA plasmids encoding a 
Notch ligand (Jag1) or activated Notch (NICD, also called RAMIC domain) were 
electroporated in the TA muscles, and Pax7 and GFP expressions were 
analyzed 7 days later (Figure 2.3C-f to Figure 2.3C-h). Overall, Jag1 
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overexpression increased the percentage of Pax7+/GFP+ satellite cells by ~30% 
(n=1,191 cells analyzed) and NICD overexpression increased the double positive 
satellite cells by ~50% ( n= 825 cells analyzed). Thus, the Cp-GFP reporter 
mouse faithfully reports Notch signaling activation in satellite cells. The single 
fiber and FACS analyses further demonstrate that Notch signaling is activated in 
a small population of quiescent satellite cells. 
I next established the Cp-GFP/MDX mouse model through crossing the 
two lines of mice and examined Cp-GFP expression. EDL myofibers were 
isolated from WT control (Cp-GFP/WT) and MDX (Cp-GFP/MDX) mice 5 days 
after CTX-induced regeneration, and labeled with Pax7 and GFP antibodies 
(Figure 2.3D). Notably, the percentage of GFP+ satellite cells (% 
GFP+Pax7+/total Pax7+) in MDX was only about half of that in WT mice after CTX 
injury(Figure 2. 3L; 37% in WT vs 20% in MDX). By contrast, there was no 
significant difference in the percentage of GFP+ satellite cells between WT and 
MDX mice under resting conditions (Figure 2.3E). This result suggests that MDX 
satellite cells have reduced activation of Notch signaling during muscle 
regeneration. Consistent with this notion, mRNA levels of Notch receptors 
(Notch1 and Notch3) and Notch ligand (Jagged1) as well as Notch target (HeyL) 
were reduced by ~50% in primary myoblasts derived from MDX mice compared 
to those from WT mice (Figure 2.3F). Taken together, the self-renewal defects of 
MDX satellite cells is associated with reduced Notch signaling transduction. 
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2.4.4 Constitutive Activation of Notch Rescues the Self-renewal Defects of 
Satellite Cells but Fails to Improve Muscle Pathology in MDX Mice  
To directly address whether reduced Notch signaling in MDX satellite cells 
is responsible for their self-renewal defects, I carried out gain-of-function studies 
using Cre/LoxP mediated conditional gene expression tools. I first cultured EDL 
myofibers from Rosa26NICD/MDX mice, and used Adenovirus-Cre to activate 
NICD expression during the culture. After 72 h of culture, myofibers were stained 
with Pax7 and MyoD (Figure 2.4A). Quantitative analysis indicates that the 
percentage of Pax7+MyoD- (self-renewal) satellite cells was drastically increased 
(from 12% to 32%) after Cre induced Notch activation, compared to the control 
Adenovirus-GFP treatment (Figure 2.4B). Meanwhile the ratio of proliferating 
(Pax7+MyoD+) cells was significantly decreased by Notch activation (Figure 
2.4B). These results demonstrate that Notch activation improves self-renewal 
and inhibits the proliferation of satellite cells in MDX mice. 
I next attempted to activate Notch signaling in MDX satellite cells in vivo. To 
do this, I established the Pax7CreER/Rosa26NICD/MDX triple transgenic mouse in 
which Notch signaling is specifically activated in MDX satellite cells upon 
Tamoxifen induction. After 5 doses of Tamoxifen injection, NICD (revealed by 
nuclear GFP expression as the Rosa26NICD mice also expression nuclear GFP 
upon Cre treatment) was specifically activated in the Pax7+ satellite cells (Figure 
2.4C). Analysis of TA muscle cross sections (Figure 2.4D) indicates that the 
number of Pax7+ satellite cells was increased significantly after Notch activation 
(Figure 2.4E). More strikingly, the percentage of Pax7+MyoD- (self-renewal) 
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satellite cells was also significantly increased (from 40% to 60%) after NICD 
overexpression (Figure 2.4F). These results provide compelling evidence that 
constitutive activation of Notch rescues the self-renewal defect of MDX satellite 
cells.  
To examine how satellite cell-specific stimulation of Notch signaling affects 
muscle pathology in MDX mice, I conducted histological analysis of TA muscles 
sections with and without CTX injury. Surprisingly, Notch activation in satellite 
cells failed to ameliorate muscle pathology and improve CTX-induced muscle 
regeneration in the MDX mice (Figure 2.4G). This is manifested by the reduced 
number of myofibers with an area of 500μm2 or greater (Figure 2.4H).  This 
observation is consistent with our recent report that constitutive Notch activation 
in satellite cells blocked muscle regeneration in WT mice (Wen et al., 2012), due 
to the well-known function of Notch signaling in inhibiting myogenic differentiation 
(Kopan et al., 1994). These data suggest that although constitutive Notch 
activation promotes self-renewal of satellite cells and increases satellite cell 
number in MDX mice, Notch signaling must be temporally suppressed during 
myogenic differentiation to allow proper progression of myogenesis. 
2.5 Discussions 
In this work, I identify that the satellite cells in MDX mice undergoes drastic 
change not only in the cell number but also in the cell activity. Specifically, the 
satellite cells in dystrophic muscles were defective in self-renewal capacity. Also, 
I verify that the Notch signaling pathway was perturbed in MDX satellite cells 
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using Notch reporter mice. Furthermore, I show that constitutive activation of 
Notch signaling rescued the self-renewal deficiency of MDX satellite cells in vitro 
and in vivo. However, constitutive activation of Notch failed to improve muscle 
regeneration in MDX mice. Nevertheless, these results suggest that aberrant 
Notch signaling is responsible for the defective self-renewal capacity and 
enhancement of Notch signaling leads to improved self-renewal of satellite cells 
in muscular dystrophy.  
Muscular dystrophy has been characterized as an inherited disease 
featuring susceptibility to muscle damage and progressive muscle wasting. Given 
the indispensable role of satellite cells in muscle regeneration (Sambasivan et al., 
2011; von Maltzahn et al., 2013) , the behavior of satellite cells, especially their 
replicative and differentiation capacity, determines the progression of muscle 
dystrophies. Primary myoblasts isolated from DMD patients have a significant 
low yield (Blau, 1983) and reduced proliferative capacity (Lamperth et al., 1990). 
Correspondingly, primary myoblasts from MDX mice exhibits accelerated 
differentiation kinetics (Yablonka-Reuveni and Anderson, 2006), supporting the 
notion that the proliferative capacity was compromised in the satellite cells in 
dystrophic muscles. Our results that the satellite cell number and proliferative 
response to CTX-stimulation declined with age in MDX mice provide direct in vivo 
evidence for age-dependent deficiencies in satellite cell activity.  
Our findings that satellite cells in dystrophic muscles are defective in self-
renewal capability are consistent with the previous study that muscle dystrophy 
results from an autonomous failure of satellite cells to maintain repetitive 
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degeneration and regeneration cycles (Sacco et al., 2010). It is worth mentioning 
that murine somatic cells have longer telomeres compared to human cells, which 
significantly decreases the replicative senescence and increase the regenerative 
capacity of MDX satellite cells (compared to DMD satellite cells). To some extent, 
this explains why the MDX mice have slower pathological progression relative to 
human DMD. However, our results indicated that the satellite cells in MDX mice 
still exhibit deficiencies in self-renewal capability. Specifically, old MDX satellite 
cells cannot replenish themselves at all in 24-month-old, while the WT non-
dystrophic satellite cells can still self-renewal (but at a significantly reduced rate 
compared to satellite cells from young animals). This finding prompted us to 
investigate the molecular mechanism behind the defective self-renewal capacity 
of MDX satellite cells. The mechanism governing the self-renewal of satellite 
cells is currently a topic of intense investigation.  Recent studies have revealed a 
number factors that induce the quiescence/self-renewal of satellite cells. These 
include Sprouty1 (Shea et al., 2010), Angiopoietin 1 (Ang1) / Tie2 pathway 
(Abou-Khalil et al., 2009), Par-complex-dependent p38α/β MAPK pathway (Troy 
et al., 2012), microRNA-489 (Cheung et al., 2012), and nitric oxide (Buono et al., 
2012). However, what signaling mechanism(s) regulate the self-renewal 
deficiency in MDX satellite cells has not been determined.  
The Notch signaling pathway plays complicated and critical roles in 
embryonic muscle development and postnatal myogenesis. Previous studies 
have demonstrated an interaction between Dystrophin and Notch pathway. In 
Drosophila, the membrane Dystrophin/Dystroglycan complex can interplay with 
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the Notch ligand Delta (Kucherenko et al., 2008), which implies that the Notch 
signaling pathway may be perturbed in the absence of Dystrophin in MDX 
muscles. This notion was supported by the microarray analysis of dystrophic 
muscles. A number of key genes involved in the Notch signaling pathway have 
been detected with altered levels in dystrophic muscles. Specifically, the Notch 
antagonist Numb is up-regulated while the Notch target genes Hes1 and Hey1 
are down-regulated drastically (Turk et al., 2005). Most recently, Church et al 
discovered a reduction of Notch1 and Hes1 mRNA level in the TA muscles of 
MDX mice and DMD patients (Church et al., 2014). However, direct in vivo 
evidence demonstrating an aberrant Notch signaling occurs in satellite cells in 
dystrophic muscles has been lacking. Using Cp-GFP as a reporter of the Notch 
signaling pathway activation, I now provide in vivo evidence that the Notch 
signaling pathway is perturbed in satellite cells of MDX muscles. This is the first 
direct in vivo evidence that the Notch signaling pathway was inhibited in satellite 
cells of dystrophic muscles. Our finding is consistent with the previous studies 
that Notch blockage in satellite cells can cause muscle dystrophic phenotype as 
well as deteriorated muscle regeneration (Lin et al., 2013). In addition, Church et 
al also show that Notch inhibition impeded the functional recovery of regenerated 
MDX muscles (Church et al., 2014). To rescue this self-renewal defect in 
dystrophic muscles, I established a mouse model to constitutively activate Notch 
signaling in satellite cells. As expected, Notch activation successfully ameliorated 
the self-renewal capacity, which corroborates that the impaired Notch signaling 
pathway contributes to the defective self-renewal capacity in the satellite cells of 
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dystrophic muscles. Therefore, Notch activation may provide a potential route to 
prevent premature depletion of satellite cells in DMD patients. Also, with the 
respective of the long-term treatment of muscle dystrophy, our studies suggest 
that the Notch inhibitor therapies may have potential side effects by accelerating 
satellite cells exhaustion. However, continuous Notch activation fails to improve 
regeneration of MDX muscles. I interpret this observation as the lack of myogenic 
differentiation due to the inhibition of MyoD and myogenin by Notch signaling. 
Taken together, a dynamic regulation of Notch signaling is necessary to balance 
self-renewal and differentiation of satellite cells in order to ameliorate the long-
term regenerative defects of dystrophic muscles. 
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Figure 2.1 B  Satellite Cell Number
Satellite cell numbers in single EDL muscle fibers were quantified from WT and 
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Figure 2.1 C  Satellite Cell Number 
Satellite cell numbers in single EDL muscle fibers were quantified from WT and 
MDX mice at indicated ages




Increases More in MDX Mice after Injury.






Figure 2.1 D  CTX-stimulated Relative Fold Change of Satellite Cell Number 
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Figure 2.1 E  Satellite Cell
Fibers from Aged MDX Mice
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Figure 2.2 A  A Subset
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Figure 2.2 C  The Abundance
MDX Muscles after Injury
Single EDL muscle fibers 
Based on Pax7 and β-gal
(Pax7+Myf5- (β-gal-)) were quanti
than 20 fibers analyzed in each mouse.
 
 
 of Self-renewal Satellite Cells Decreases 
. 
were isolated from WT and MDX mice after CTX injury. 
 staining, percentages of self-renewal satellite cells 
fied at the indicated ages. n=3 mice with more 
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Figure 2.2 E  Different Subpopulations in Satellite Cell Clusters
through Self-renewal, Proliferation and Differentiation
Single fibers from WT and MDX mice 
clusters were formed in the 
Pax7 (red) and MyoD (green)
were labeled by Pax7+MyoD




were cultured for 72hs. Satellite cell 
single fiber culture. Satellite cell were labeled with 
. Quiescent, proliferating and differentiating c
-, Pax7+MyoD+, and Pax7-MyoD staining, 




 Are Going 
ells 
 
Figure 2.2 F  Self-renewal Capacity 
Single fibers from WT and MDX mice 
subpopulations of cells in one cluster 
staining. n=3 independent experiment with more than 20 clusters analyzed in 
each experiment. Error bars represent s.e.m. *P<0.05.
 
Is Reduced in MDX Satellite Cells.
were cultured for 72hs. Percentages of 







Figure 2.2 G  A Subset of
Differentiate. 
Single fibers from WT and MDX mice 
clusters were formed in the 
myogenin (red) and MyoD (green)
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Figure 2.2 H  MDX Satellite Cells 
Single fibers from WT and MDX mice 
myogenin+ cells per cluster 
staining. n=3 independent experiment with more than 20 clusters analyzed in 
each experiment. Error bars represent s.e.m. *P<0.05.
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Figure 2.3 A  The Notch Signaling Pathway 
Muscles. 
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Figure 2.3 B  The Notch Signaling Pathway 
Muscles 
RNA were extracted from TA muscles
months age. n=6 mice for each group.
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 collected from WT and MDX mice
 Error bars represent s.e.m. *P<0.05.
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Figure 2.3 C  The Cp-GFP Transgenic Mouse Is a Faithful Reporter of Notch 
Signaling in Satellite Cells.  
(a) GFP signal in a putative satellite cell on a freshly isolated live EDL myofiber. 
(b) Double labeling with Pax7 (Red, satellite cell marker) and GFP (Green) 
indicates that 83% satellite cells (Pax7+) are GFP- (b1), but 17% are GFP+ (b2, 
n=102 cells counted from 3 mice). (c) Isolation of GFP+ and GFP- satellite cells 
from the Cp-GFP mouse by fluorescent activated cell sorting using a7-integrin as 
a positive selection marker. (d) Analysis of sorted a7-integrin+ cells indicates that 
8% of cells are GFP+. (e) Realtime PCR analysis indicate that sorted GFP+ 
satellite cells expressed higher levels of Hes1, a canonical target of Notch 
signaling. (f-h) Activation of Notch signaling turns on Cp-GFP in satellite cells in 
vivo. Shown are images of Pax7 and GFP staining in control (f), Jag1 
overexpressing (g), and RAMIC (NICD) overexpressing (h) TA muscle sections 7 
days after electroporation of plasmids encoding empty vector, Jag1 cDNA and 
NICD cDNA, respectively. Arrows point to Pax7+/GFP+ satellite cells. Figure 2.3 




Figure 2.3 C  The Cp-GFP Transgenic Mouse Is a Faithful Reporter of Notch 





Figure 2.3 D  The Notch Signaling Pathway 
Cells. 
Single EDL muscle fibers 
attached on the fibers were labeled with 
asterisk and arrow represent Pax7+GFP+ and Pax7+GFP
respectively. Nuclei were counterstained with
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Figure 2.3 E  The Notch Activity 
Injury. 
Single EDL muscle fibers 
CTX injury. Based on Pax7 and GFP staining, percentages of Notch active 
satellite cells were quantified
each mouse. Error bars represent s.e.m. *P<0.05.
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Figure 2.3 F  The Notch Signaling Pathway 
WT and MDX primary myoblast were cultured and collected for qPCR analysis 
including Notch receptors (Notch 1, 2, and 3) and ligand (Jagged1) as well as 
Notch target genes (Hey1 and Hey
performed.  Error bars represent s.e.
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Figure 2.4 A  Different Subpopulations in Satellite Cell Clusters 
through Self-renewal, Proliferation and Differentiation
Muscle fibers from Rosa26
Adenovirus (GFP and Cre) for 24 more hours. The cell clusters were labelled 
with Pax7 (red) and MyoD (green).
cells were labeled by Pa
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Figure 2.4 B  Notch Activation Promotes Self
Percentages of subpopulations of cells in one cluster 
Pax7 and MyoD staining. 
clusters analyzed in each experiment. Error bars represent s.e.m. *P<0.05.
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Figure 2.4 C  Tamoxifen 
of MDX/NICD+ Mice. 
After tamoxifen injections, m
MDX/NICD+ (Pax7CreER/+
Pax7 (red) and GFP (green). Nuclei were counterstained with DAPI (blue).
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Figure 2.4 D  Different Subpopulations of 
Self-renewal, Proliferation and Differentiation
Two-month-old MDX/NICD
with Tamoxifen for 5 consecutive days. Then TA muscles were injected with CTX 
and samples were collected 7 days after CTX injection. TA cross sections were 
stained with Pax7 (red) and MyoD (green). Nuclei were counters
(blue). 
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Figure 2.4 E  The Activation of Notch Increases Satellite Cell Number in 
MDX Muscles. 
After staining with Pax7, the number of satellite cells per field was quantified. 












Figure 2.4 F  The Activation of Notch 
renewal in MDX Muscles
After staining with Pax7 and MyoD, the ratios of self
(Pax7+/MyoD-) per field were quantified. 
were analyzed in each mouse. 
 
 
in Satellite Cells Increases 
. 
-renewal satellite cells 
n=3 mice with more than five fields 








Figure 2.4 G  The Activation of Notch in Satellite Cells Deteriorates Muscle 
Regeneration in MDX Mice.
Two-month-old MDX/NICD
with Tamoxifen for 5 consecutive days. Then TA muscles were injected with 
and samples were collected 7 days after CTX injection. TA cross sections 













Figure 2.4 H  The Activation of Notch in MDX Satellite Cells Leads to Less 
Myofiber Formation in MDX Muscle.
The number of myofibers 





(>500 µm2) per field (1 mm2) was calculated. 








CHAPTER 3. CHARACTERIZATION OF THE ROLES OF BEX1 IN 
MYOGENESIS 
3.1 Abstract 
Muscle regeneration is a complex but precisely orchestrated process 
involving spatiotemporal regulation of genes critical for myogenesis. Brain 
expressed x-linked gene 1 (Bex1) has recently been reported to be involved in 
muscle regeneration. How Bex1 regulates myogenesis, however, is completely 
unknown. To address this question, I first characterized the expression pattern of 
Bex1 in muscle development and regeneration. Bex1 is expressed following 
myogenic differentiation during embryonic muscle development. In adult muscle 
regeneration, Bex1 is highly induced in the early stage of regeneration and 
gradually disappears with muscle recovery. Consistently, in cultured myoblasts, 
Bex1 was not expressed at the proliferation stage but highly expressed upon 
induction of myogenic differentiation. Interestingly, Bex1 protein was mainly 
localized to the nucleus of newly differentiated myotubes, suggesting a role of 
Bex1 in regulating muscle gene expression. Using gain- and loss-of-function 
studies in cultured myoblasts, I observed that overexpression of Bex1 did not 




Conversely, Bex1 knockout myotubes exhibited fusion defects. These results 
elucidate a novel role of Bex1 in myogenesis through regulating myoblast fusion. 






Under normal conditions, mammalian adult skeletal muscle is relatively 
stable with little nuclei turnover, no more than 1-2 percent per week 
(Schmalbruch and Lewis, 2000). However, skeletal muscle is susceptible to a 
variety of injuries. Upon injury, skeletal muscle has the outstanding capacity to 
initiate a rapid and extensive repair process, known as muscle regeneration, to 
prevent further muscle loss. Of note, muscle stem cells, satellite cells, play 
indispensable roles in muscle regeneration (Sambasivan et al., 2011; von 
Maltzahn et al., 2013). In the early stage of muscle regeneration, satellite cells 
are activated from quiescence and proliferate as myoblasts to generate a 
sufficient number of cells. Subsequently, a majority of the proliferating myoblasts 
withdraw from the cell cycle and fuse to the injury sites to repair muscle damage. 
The mechanism involved in muscle regeneration consists of multiple signaling 
pathways. Unraveling the regulatory network behind muscle regeneration has 
drawn intense research attention in the field.  
Myoblast fusion is a crucial cellular process contributing to muscle 
regeneration as well as muscle growth and development. Myoblast fusion is 
characterized by cell attraction, migration, adhesion, and alignment followed by 
the membrane rearrangement and finally resolution (Doberstein et al., 1997). The 
fusion process occurs at two phases. The primary stage leads to the formation of 
nascent myotubes with few nuclei from myoblast-myoblast fusion. The secondary 
stage results in the formation of large syncytia with increased nuclear number 




(Horsley and Pavlath, 2004). Many progresses have been made in unraveling 
signaling pathways behind myoblast fusion in Drosophila, which occurs between 
two genetically different cell subpopulations of founder and fusion-competent 
myoblasts (Abmayr and Pavlath, 2012). Of note, ELMO-Myoblast city-Rac 
pathway has been determined to play essential roles in myoblast fusion (Duan et 
al., 2012; Geisbrecht et al., 2008; Rushton et al., 1995). Intriguingly, this 
signaling pathway is well conserved between Drosophila and vertebrates. It has 
been reported that ELMO-DOCK1 (ortholog of Myoblast city)-Rac also 
coordinately control the myoblast fusion in mice (Laurin et al., 2008). 
Furthermore, the ELMO-DOCK1-Rac pathway is under the control of brain-
specific angiogenesis inhibitor (BAI) family members, including BAI1 and BAI3, 
both of which have been corroborated to promote myoblast fusion (Hamoud et al., 
2014; Hochreiter-Hufford et al., 2013). Nevertheless, the signaling pathways 
controlling myoblast fusion in vertebrates remains largely elusive. 
The relevance of Brain Expressed X-linked gene 1 (Bex1) in muscle 
regeneration was discovered in a microarray aimed to identify a panel of genes 
with altered expression in cardiotoxin (CTX) induced muscle injury, a well-
established model for muscle regeneration (Goetsch et al., 2003; Yan et al., 
2003). It was also supported by the observation that the expression level of Bex1 
was dysregulated in MDX mice (Turk et al., 2005), which undergo progressive 
muscle degeneration and regeneration. Bex1 knockout mice displayed altered 




differentiation (Koo et al., 2007). However, the detailed mechanism of how Bex1 
is involved in muscle regeneration has been lacking. 
Bex1 belongs to a small growing family including six members with high 
homology in gene sequences and structures but distinct in the expression pattern 
and subcellular localization (Alvarez et al., 2005). Until now, the functions of 
Bex1 have been largely unknown. Bex1 has been identified as a neuron 
regeneration gene, as Bex1 knockout mice are deficient in axon regeneration 
after sciatic-nerve injury(Khazaei et al., 2010). In addition, Bex1 levels are cell-
cycle dependent in PC12 neuron cells, with the lowest expression level in G1 
phase and the highest level in S phase. Moreover, down-regulation of Bex1 is 
necessary for neuron cells to exit the cell cycle, as overexpression of Bex1 
results in sustained cell proliferation even under growth arrest conditions. Further 
studies have confirmed that Bex1 regulates cell cycle by interacting with p75 
neurotrophin receptor (p75NTR) to regulate the neurotrophin signaling pathway 
(Vilar et al., 2006). Besides its roles in the nervous system, Bex1 has been 
determined as a candidate tumor suppressor gene because its inactivation is 
associated with the development of various types of tumors (Foltz et al., 2006; 
Karakoula et al., 2014; Lee et al., 2013).    
In this study, I observed that Bex1 is expressed after the induction of 
myogenic differentiation and undergoes nuclear-cytoplasmic trafficking during 
embryonic muscle development. I also characterized that Bex1 is temporally 
induced during muscle regeneration. Consistently, I demonstrated that Bex1 is 




study, I determined that Bex1 promotes myoblast-myotube fusion without 
affecting myogenic differentiation per se. Conversely, primary myoblasts from 
Bex1 knockout mice are defective in fusion, although Bex1 knockout mice can 
regenerate their injured muscles normally. These data suggested that Bex1 is 
actively involved in the process of myogenesis by regulating myoblast fusion. 
3.3 Materials and Methods 
3.3.1 Animals  
All procedures involving animal maintenance and experimental use were 
performed based on the instructions established by Purdue University’s Animal 
Care and Use Committee. Bex1 KO mice were provided by Prof. Frank L. 
Margolis (Koo et al., 2007). Bex1 heterozygous mice were bred to generate Bex1 
null and wild type littermates used as control in the experiments. The PCR 
genotyping was done as previously described (Koo et al., 2007). 
3.3.2 Muscle Injury and Regeneration  
Muscle regeneration was induced by intramuscular injection of Cardiotoxin 
(CTX; Sigma-Aldrich, St. Louis, MO). Mice were anesthetized with a ketamine-
xylazine cocktail, then 50μl of 10 mM CTX was injected into the Tibialis Anterior 
(TA) muscle. Muscles were harvested at day 5 and 14 post injection for 





3.3.3 Culture of skeletal muscle derived primary cells  
Primary cells were isolated from limb skeletal muscles of 2-month old mice. 
Muscles were minced and digested with a cocktail of type I collagenase and 
dispase B mixture (Roche Applied Science) and subsequently cultured in growth 
media (F-10 Ham’s medium supplemented with 20% fetal bovine serum, 4 ng/mL 
basic fibroblast growth factor, and 1% penicillin-streptomycin) on collagen-coated 
dishes. Upon confluence, cells were differentiated in myogenic differentiation 
media (DMEM supplemented with 2% horse serum and 1% penicillin-
streptomycin). 
3.3.4 Cryosection  
Fresh muscles were embedded in optimal cutting temperature (OCT) 
compound (Sakura Finetek) and immediately frozen in dry ice-cooled isopentane. 
Muscle blocks were cut by 10μm with a Leica CM 1850 cryostat instrument. The 
sections were placed on Superfrost Plus glass slides (Electron Microscopy 
Sciences). 
3.3.5 Immunostaining and Image Capture  
Muscle tissue sections and cell cultures were first fixed in 4% PFA solution 
and blocked in the blocking buffer containing PBS, 5% goat serum, 2% bovine 
serum albumin, 0.2% Triton X-100 and 0.1% sodium azide for 1 hour. Next, the 
sections or cell cultures were incubated with primary antibodies diluted in 
blocking buffer overnight at 4℃, then incubated with secondary antibodies and 




temperature, and finally mounted with Dako fluorescent mounting media 
(Glostrup, Denmark). Fluorescent pictures were taken with a Coolsnap HQ CCD 
camera (Photometrics, USA) driven by IP Lab software (Scanalytics, USA) in a 
Leica DMI 6000B fluorescent microscope (Mannheim, Germany). As the analysis 
of the immunofluorescence was qualitative, identical image handling and 
fluorescence scoring criteria were applied in all the experiments. 
3.3.6 Recombinant Adenovirus Construction and Infection  
Recombinant adenoviruses expressing Bex1 were constructed using the 
Adeasy system, including the adenoviral plasmid (pAdEasy-1) and the shuttle 
vector (pAdTrack-CMV), both of which were kindly provided by Prof. Yongxu 
Wang. The sequence of Bex1 was PCR amplified and cloned into the pAdTrack-
CMV vector. The recombination with the Adeasy1 plasmid and transfection to 
HEK293 cells as well as amplification of the recombinant adenovirus were 
performed as previously described (He et al., 1998). For infection experiments, 
myoblasts were grown to 80% confluence and infected with virus for 48h at 37°C. 
3.3.7 Quantitative Real-time Polymerase Chain Reaction  
RNA was extracted and purified from muscles or cell cultures using Trizol, 
followed by the digest with Turbo DNase (Ambion). Random hexamer primers 
were used for the reverse transcription from RNA to cDNA. qPCR was performed 
with a Light Cycler 480 machine (Roche). 18s was used as housekeeping gene 
for normalization. For qPCR result analysis, 2-∆∆ct method was applied to 




3.3.8 Protein Extraction and Western Blots Analysis  
Total protein was extracted from muscles or cells using RIPA buffer 
containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 0.5% 
sodium deoxycholate, and 0.1% sodium dodecyl sulfate (SDS). Protein 
concentrations were measured by Pierce BCA protein assay reagent (Pierce 
Biotechnology, Rockford, IL, USA). Proteins were separated by SDS–
polyacrylamide gel electrophoresis (SDS-PAGE), transferred to PVDF 
membranes (Millipore Corp., Billerica, MA), and probed with specific antibodies 
(Bex1, 1:5000 dilution, provided by Prof. Frank L. Margolis; Pax7, 1:10 culture 
supernatant, DSHB, U Iowa; myogenin, 1:1000 dilution, Santa Cruz 
Biotechnology; GAPDH, 1:1000 dilution, Santa Cruz Biotechnology), then 
detected by chemiluminescence with FluorChem™ R System (ProteinSimple, 
Santa Clara, CA, USA). 
3.3.9 Statistical Analysis  
Data are displayed with mean ± s.e.m. P-values were calculated by two-
tailed Student’s t-test. P-values <0.05 were considered to be statistically 
significant. 
3.4 Results 
3.4.1 Bex1 Expression during Muscle Development and Regeneration 
Previous studies demonstrated that Bex1 is predominantly expressed in 
the central nervous system. Besides, it is widely expressed in various tissues 
with high levels in the liver but less abundance in skeletal muscles (Alvarez et al., 




somatic mesenchyme during muscle development (Vilar et al., 2006). Here I 
sought to further characterize the in vivo expression pattern of Bex1 during 
skeletal muscle development and regeneration. 
In the mouse embryonic muscle development, Pax7 and myogenin have 
been regarded as markers of muscle progenitor cells and differentiated myocytes, 
respectively (Cheng et al., 1992; Relaix et al., 2006; Venuti et al., 1995). Using a 
Bex1 antibody, I detected immunofluorescence in developing somites at 
embryonic day (E) 10.5. Co-localization analysis indicates that Bex1 is absent in 
the Pax7-expressing cells but co-localizes with a subpopulation of myogenin-
expressing myogenic cells (Figure 3.1A), indicating that Bex1 is only expressed 
in differentiating or differentiated muscle cells. Interestingly, analysis of 
intracellular localization indicates that Bex1 is located in the cytoplasm at E10.5 
but in the nucleus at E12.5 (Figure 3.1B). The late expression of Bex1 in 
myogenin-expressing cells suggests that Bex1 might play a role in myogenic 
differentiation. 
I also examined the expression pattern of Bex1 in postnatal muscle 
regeneration. Before muscle injury, Bex1 was barely detectable in rested 
muscles (Figure 3.1C), suggesting that Bex1 is not required for maintaining 
normal muscle function. During muscle regeneration, Bex1 was highly induced in 
the cytoplasm of regenerating muscles at Day 5 but its expression disappeared 
at Day 14 (Figure 3.1C), indicative of a spatiotemporal expression pattern. In 
agreement with this observation, Bex1 transcript level was detected to peak at 




expanded and are fusion competent (Robertson et al., 1990). Then Bex1 
expression gradually disappeared afterwards until nearly undetectable at Day 14 
(Figure 3.1D), when the muscle regeneration is largely completed. Altogether, 
these data indicate that Bex1 is actively involved in embryonic and postnatal 
myogenesis. 
3.4.2 Bex1 is Exclusively Expressed in Differentiated Myoblasts in vitro.  
In order to better understand the role of Bex1 in the myogenesis, I also 
examined the expression pattern of Bex1 in cultured primary myoblasts. In 
agreement with the expression pattern of Bex1 in embryonic muscle 
development, Bex1 is absent in proliferating myoblasts while its expression is 
highly induced by differentiation (Figure 3.2A). Consistently, the expression 
levels of Bex1 mRNA and protein were increased in differentiated myocytes 
compared to undifferentiated myblasts (Figure 3.2B and 2C). In addition, Bex1 
expression is limited to the nuclei of differentiated myotubes (Figure 3.2A). 
Moreover, single fiber culture experiment was performed to investigate the Bex1 
expression pattern in myoblasts attached to the host fiber. After culture for 72 
hours, Bex1 is not expressed in Pax7+ (Figure 3.2D) or KI67+ cells (Figure 
3.2E), supporting the notion that Bex1 is not expressed until differentiation. While 
the expression of Bex1 emerged in the myogenin+ cells, mainly in the nucleus 
but also in the cytoplasm (Figure 3.2F), confirming that Bex1 is induced upon 
myogenic differentiation. Notably, given the lack of Bex1 localization in the 
nucleus of mature myotubes, these data suggest that Bex1 undergoes a nucleus 




exclusive expression pattern of Bex1 in nascent myotubes prompted us to 
explore the roles of Bex1 in myogenic differentiation. 
3.4.3 Bex1 does not Regulate Cell Cycle Withdrawal in Myogenic Cells.  
Prior studies demonstrated that overexpression of Bex1 in neuron cells 
renders resistance to NGF- or serum withdrawal-induced growth arrest, whereas 
Bex1 knockdown led to cell cycle exit and premature differentiation. Furthermore, 
Bex1 was determined to interact with p75NTR to regulate cell cycle withdrawal 
(Vilar et al., 2006). Given that Bex1 is cell-cycle-regulated with the lowest in G1 
phase and highest in S phase in neuron cells, I first examined whether Bex1 
could be accumulated in the specific phase of cell cycle. However, I observed 
that Bex1 was undetectable with treatment of mimosine, thymidine, and 
nocodazole (arresting cells in the G1, S, G2/M phase, respectively) (Figure 
3.3A), which suggests that Bex1 is not dependent on cell cycle progression. 
Moreover, I performed FACS analysis on undifferentiated myoblast infected by 
adenovirus expressing GFP and Bex1. The ectopic expression of Bex1 in 
proliferating myoblasts failed to promote cell cycle withdrawal, indicated by the 
comparable distribution of cells in G1, S, G2/M phase (Figure 3.3B). 
Quantification of different cell groups confirmed that Bex1 overexpression did not 
affect the percentages of myoblast population in G1, S and G2/M phases. 





3.4.4 Bex1 Promotes Myoblast-Myotube Fusion in vitro.  
I further investigated the mechanism of how Bex1 regulates myogenic 
differentiation. It was reported that Bex1 can directly interact with Calmodulin 
(CaM), the ubiquitous Ca2+ -binding protein, in a Ca2+-dependent manner in vitro 
(Koo et al., 2007). CaM can activate multiple CaM-dependent enzymes, such as 
Calcineurin, to mediate the regulatory effect of Ca2+ signaling pathway, which 
plays indispensable roles in the fusion of myoblast into multinucleated myotubes 
(Bar-Sagi and Prives, 1983; Bijlenga et al., 2000; Constantin et al., 1996; Shin et 
al., 1996).  
To test whether Bex1 is involved in the myoblast fusion, I performed gain-
of-function study on primary myoblasts. Bex1 mRNA transcript and protein were 
significantly increased after infection (Figure 3.4A and 3.4G). After differentiation 
for 24hs, both GFP control and Bex1 overexpressed myoblasts started to form 
nascent myotubes with few nuclei and are indistinguishable in myofiber size 
(Figure 3.4B), confirmed by comparable differentiation index and fusion index 
(Figure 3.4C and 3.4D). This suggested that Bex1 did not regulate the initial 
formation of myotubes. Interestingly, after differentiation for 96hs, Bex1 
overexpression caused a dramatic accumulation of nuclei in mature myotubes 
(Figure 3.4E). The percentages of myofibers with more than 5 nuclei was 
markedly increased by Bex1 overexpression (13.56% vs 26.70%) (Figure 3.4F), 
suggesting that Bex1 positively regulates myoblast fusion with myotubes. 
However, the expression of myogenic differentiation markers, myogenin and 




indicating that Bex1 functions specifically through promoting myoblast fusion 
rather than regulating myogenic differentiation per se. Meanwhile, I also 
electroporated plasmid encoding Bex1 to C2C12 myoblasts to investigate the 
roles of Bex1 in myoblast fusion (Figure 3.4H). Consistently, the average 
number of myonuclei inside Bex1 overexpressed myotubes increased 
dramatically (4.7 vs 9.4) (Figure 3.4I), supporting the notion that Bex1 could 
promote myoblast fusion. Altogether, these data suggest that Bex1 promotes 
myoblast fusion without affecting myogenic differentiation. 
3.4.5 Bex1 Knockout Myoblasts are Defective in Myoblast-myotube Fusion in 
vitro.  
To confirm definitively that Bex1 promotes myoblast fusion, I bred Bex1 
heterozygous mice to obtain the knockout mice. I administrated CTX to injure TA 
muscles and allowed muscle regeneration for 14 days. The Bex1 knockout 
muscles did not exhibit obvious regeneration defects at day 5 and day 14. 
Through laminin staining, I quantified the size of regenerated myofibers, a direct 
indicator of myoblast fusion. Bex1 knockout mice did not exhibit obvious fusion 
defects (Figure 3.5A), indicated by a cohort of indistinguishable fiber diameter 
classes (Figure 3.5B).  
By culturing primary myoblast from Bex1 knockout mice, I performed a loss-
of-function study to investigate the effects of loss of Bex1 on myoblast fusion in 
vitro. The primary myoblasts from Bex1 knockout mice were normal in terms of 
proliferation capacity like WT myoblasts, indicated by normal growth curve and 




not shown). After differentiation for 24hs, Bex1 knockout myoblasts formed 
nascent myotubes normally, which is comparable with WT control in terms of 
nuclei number in the myotubes and fiber size (data not shown). However, after 
differentiation for 96hs, WT control myoblasts formed large myofibers with 
multiple nuclei inside whereas Bex1 knockout myoblasts failed to enlarge fiber 
size and accumulate myonuclei efficiently (Figure 3.5C). The percentages of 
myofibers with more than 5 nuclei was significantly reduced (43.43% vs 24.45%) 
(Figure 3.5D), suggesting that Bex1 knockout led to significant defects of 
myoblast fusion with myotubes. Besides, in accordance with the notion that Bex1 
overexpression did not affect myoblast differentiation, knocking-out Bex1 did not 
impair the myoblast differentiation per se, indicated by the comparable 
expression levels of myogenic differentiation markers, myogenin and MHC 
(Figure 3.5E). Altogether, these data provided compelling evidence that Bex1 
promotes myoblast-myotube fusion. 
3.5 Discussions 
In this study, I identified that Bex1 is expressed following myogenic 
differentiation during embryonic muscle development as well as temporarily 
induced during muscle regeneration. I also determined that Bex1 is specifically 
expressed in differentiated myocytes in vitro. Of note, Bex1 undergoes 
translocation from the cytoplasm to the nucleus as differentiation proceeds. I 
verified that Bex1 can promote myoblast-myotube fusion without affecting 
differentiation progression. Conversely, I demonstrated that Bex1 knockout 




the role of Bex1 in myogenesis that Bex1 could promote myoblast-myotube 
fusion. 
It has been well documented that Bex1 is abundantly expressed in neurons 
with a dynamic nucleocytoplasmic distribution pattern. This nucleocytoplasmic 
trafficking was associated with neuron growth factor (NGF) induced p75NTR 
signaling pathway (Lee et al., 2013). Here, I also observed the nucleocytoplasmic 
distribution pattern in myogenic cells. Bex1 was initially diffused in the cytoplasm 
but translocated to the nucleus in the late stage of differentiation. This 
nucleocytoplasmic trafficking could also be related to the p75NTR signaling 
pathway as p75NTR has been reported to have high expression levels in 
developing rat myoblasts as well as in rat and chicken muscles (Ernfors et al., 
1988; Lomen-Hoerth and Shooter, 1995; Raivich et al., 1985; Raivich et al., 1987; 
Schecterson and Bothwell, 1992; Yamamoto et al., 1996). Another possible 
signaling pathway is the Ca2+ dependent signaling pathway, which plays 
indispensable roles in myogenic differentiation. It has been reported that Bex1 
can directly interact with Calmodulin (CaM) (Koo et al., 2007), the ubiquitous 
Ca2+ -binding protein, which mediates the uptake of various nuclear proteins 
(Sweitzer and Hanover, 1996), such as NFAT isoforms. Future work can be 
focused on investigating which signaling pathway controls the nucleocytoplasmic 
trafficking of Bex1 in myogenesis. 
Mammalian skeletal muscles are generated through the proliferation, 
differentiation and fusion of myoblasts into multinucleated myofibers. The 




in critical steps during myogenic differentiation. Previous studies demonstrated 
that Bex1 knockout mice posed prolonged proliferation and delayed 
differentiation kinetics compared to WT mice during muscle regeneration (Koo et 
al., 2007), indicating the defects of cell cycle withdrawal due to the loss of Bex1. 
However, our studies show that the myoblasts cultured from Bex1 knockout mice 
were not defective in proliferation in vitro. Also, Bex1 ectopic expression did not 
regulate cell cycle withdrawal and further myogenic differentiation per se. The 
observation of prolonged proliferation and delayed differentiation might be due to 
other cell types in that muscle regeneration involves proliferation of various types 
of cells, such as immune cells.  
Furthermore, I verified that Bex1 could positively regulate myoblast fusion. 
Interestingly, the myoblast-myoblast fusion was not affected by either Bex1 
overexpression or knock-out. However, the ectopic expression of Bex1 
dramatically increased the myoblast-myotube fusion in vitro while Bex1 knockout 
myoblasts were defective in the process. Recently, it was reported that apoptotic 
cells can induce ELMO/DOCK1/Rac pathway through the cell surface protein 
BAI1 to enhance myoblast fusion (Hochreiter-Hufford et al., 2013).  Besides, 
Bex3 has been identified to interact with p75NTR to mediate apoptosis pathway 
(Mukai et al., 2000). Given that Bex1 and Bex3 share the similar sequences 
implicated in p75NTR binding (Vilar et al., 2006), it is plausible to hypothesize 
that Bex1 could promote apoptosis during myogenic differentiation, which 
initiates the ELMO/DOCK1/Rac signaling pathway and mediates the fusion. 




deficient myoblast fusion as well as impaired muscle regeneration. This might be 
attributable to the compensation effect of other Bex family members due to the 
loss of Bex1. Or, the massive degeneration overwhelmed the effect of loss of 
Bex1 on cell apoptosis, which further masked the defects of myoblast fusion. 
Generating Bex1 transgenic mice may provide additional clues to study the roles 
of Bex1 in muscle regeneration. Nevertheless, this study contributes to our 
understanding the cellular and molecular mechanism of myogenesis, especially 
the myoblast fusion. These data may have implication in the development of 
therapeutic strategies of muscle diseases. 
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Figure 3.1 A  Bex1 Is Expressed During Myogenic Differentiation 
Embryos at E10.5 stage were sectioned and applied in the immunostaining with 
antibodies recognizing Bex1 (green) together with Pax7 (red, 
myogenin (red, right panel




), showing a concurrent expression pattern of Bex1 








Figure 3.1 B  Bex1 Translocates from Cytoplasm to Nucleus 
Differentiation in vivo
Embryos at E10.5 (left 
and applied in the immunostaining with antibodies recognizing 
and Bex1 (green). Bex1 undergoes cytonucleotrafficking from cytoplasm at E10.5 





panels) and E12.5 stage (right panels) were sectioned 
myogenin (red) 






Figure 3.1 C  Bex1 Is Temporarily Expressed during Muscle Regeneration
TA muscles were injected with CTX and samples were collected at indicated 
points after CTX injection. TA cross se
were counterstained with DAPI (
 
 







 (red). Nuclei 
 
Figure 3.1 D  Bex1 Is Highly Induced at Day 5 post Injury but Gradually 
Disappears afterwards
TA muscles were injected with CTX and sam
points after CTX injection. RNA were extracted from muscles and compared 
between rested and injured muscles at different time points. The dot line 
indicates the expression level of Bex1 in rested muscles. N=3. 












Figure 3.2 A  Bex1 Is Exclusively Expressed in Differentiated Myocytes
Primary myoblasts were cultured and induced for different
different days post differentiation induction was applied in the immunostaining 




iation. Cell culture at 







Figure 3.2 B  The Expression 
Differentiation. 
Primary myoblasts were cultured and induced for different





Level of Bex1 Tanscript Is Increased with 
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Figure 3.2 C  The Expression Level of Bex1 Protein Is Increased with 
Differentiation. 
Primary myoblasts were cultured and induced for different












Figure 3.2 D  Bex1 Is Not Expressed in Undifferentiated Myoblasts
Single fibers were isolated and cultured for 72












. Nuclei were 
 
Figure 3.2 E  Bex1 Is Not Expressed in 
Single fibers were isolated and cultured for 72














. Nuclei were 
 
Figure 3.2 F  Bex1 Is Expressed in Differentiated Myoblast
Single fibers were isolated and cultured for 72






hs. Satellite cell clusters were 
myogenin (red, 







Figure 3.3 A  Bex1 Is Not Cell
Primary myoblasts were cultured and treated with mimosine, thymidine, and 
nocodazole, which can arrest cells at G1, S, and G2/M phases,
undifferentiated myoblast. D, differentiated myotubes.




 respectively. UD, 







Figure 3.3 B  The Ectopic Expression of Bex1 Does Not Promote 
Withdrawal. 
Primary myoblasts were infected with virus expressing GFP and Bex1 for 48hs. 
Cell population at different phases of cell cycle were separated by FACS. 













Figure 3.4 A  The Expression Level of Bex1 Transcript 
Infection of Adeno-virus Expressing Bex1.
Primary myoblasts were cultured and i
Bex1 for 48hs. RNAs were extracted and compared between GFP and Bex1 





nfected with virus expressing GFP and 








Figure 3.4 B  The Bex1 Over
myoblast Fusion. 
Primary myoblasts were
and Bex1 upon confluence. After 24hs differentiation
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 cultured and differentiated with viruses expressing GFP 







Figure 3.4 C  The Bex1 Over
Differentiation 
Primary myoblasts were
and Bex1 upon confluence. After 24hs differentiation
calculated as the ratio of nuclei in Myosin+ cells. 
 
 
-expression in Myoblast Does Not Affect Early 
 cultured and differentiated with viruses expressing GFP 








Figure 3.4 D  The Bex1 Over
Primary Fusion. 
Primary myoblasts were
and Bex1 upon confluence. After 24hs differentiation
as the ratio of nuclei in Myosin+ myotubes. n=3.
 
 
-expression in Myoblasts Does Not Affect 
 cultured and differentiated with viruses expressing GFP 








Figure 3.4 E  The Bex1 
Fusion. 
Primary myoblasts were
differentiation, adeno-virus expressing GFP and Bex1 was added with
hours differentiation and then immunostained 
(red). Nuclei were counterstained with DAPI (cyan).
 
 
Over-expression Promotes Myoblast-myotube 
 cultured and differentiated upon confluence. After 24hs 
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Figure 3.4 F  The Bex1 Over
Fusion. 
Primary myoblasts were
expressing GFP and Bex1. Percentages of myosin+ cells with different nuclei 





-expression Increases Myoblast-myotube 
 cultured and differentiated with infection of virus 
≥ 200 cells were analyzed with 5 






Figure 3.4 G  The Bex1 Over
Differentiation per se.
Primary myoblasts were
expressing GFP and Bex1. Proteins were extracted after differentiation and 




-expression Does Not Affect Myoblast 
 







Figure 3.4 H  The Bex1 
Myoblasts. 
C2C12 myoblasts were electroporated with plasmids expressing GFP and GFP
Bex1 then induced for differentiation for 6 days. Myotubes were 




Over-expression Promotes Fusion in C2C12 
immunostain







 with DAPI 
 
Figure 3.4 I The Bex1 Over
C2C12 Myotubes. 
After immunostaining with the MHC antibody, t
GFP-Bex1+ myotubes 
bars represent s.e.m. *P<0.05 compared with GFP
 
-expression Increases the Number of Nuclei
he numbers of nuclei in 











Figure 3.5 A  The Myofiber Size in 
after Regeneration. 
TA muscles from WT and Bex1 Knock
days regeneration, TA muscles were sectioned and stained with antibody against 
laminin (green). N=3 mice.
 
Bex1 Knockout Mice Appears Normal 








Figure 3.5 B  Bex1 Knockout Mice Do Not 
Regeneration. 
After CTX-induced muscle regeneration for 14 days, TA muscles were sectioned 
and stained with antibody against laminin (green). The fiber size
calculated by ImageJ plus software. N=3.
 
 









Figure 3.5 C  Primay Myoblast
Myoblast-myotube Fusion.
Primary myoblasts were
differentiated for 72hs upon confluence.
antibody recognizing MHC (red). Nuclei were counterstained with DAPI (cyan).
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 cultured from WT and Bex1 knockout mice a
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Figure 3.5 D  Bex1 Knockout Leads to the Defective Myoblast
Fusion. 
Primary myoblast from WT and Bex1 knockout mice were
differentiated for 72hs upon conflunce. Percentages of myosin+ cells with 
different nuclei number in each field were calculated. 
with 3 independent experiments. 




 cultured and 
≥ 200 cells were analyzed 







Figure 3.5 E  Bex1 Knockout Does Not Affect Myogenic Differentiation 
se. 
Primary myoblasts were
differentiated upon confluence. Proteins were extracted after differentiation and 














CHAPTER 4. IMPLICATION AND FUTURE DIRECTIONS 
4.1 Implication 
Muscle regeneration is a highly orchestrated process involving multiple 
types of cells, including satellite cells and a poorly determined collection of cell 
populations. In response to environmental cues, those cells could adapt and 
cooperate with each other to maintain or recover homeostasis in skeletal 
muscles, wherein a spectrum of signaling pathways and transcriptional factors 
have been determined to regulate cellular behaviors. Of note, satellite cells play 
pivotal roles in contributing to muscle regeneration and satellite cell activation, 
proliferation and differentiation are precisely controlled by a cellular and 
molecular regulatory network. However, under some pathophysiological or aging 
conditions, the delicate balance of the cellular and molecular regulatory network 
could be perturbed so that muscle wasting may ensue, which is extremely 
detrimental to health and may even lead to death. The studies in this dissertation 
aim to explore the cellular and molecular mechanism of muscle regeneration in 
MDX mouse, a well-characterized model for Duchenne muscular dystrophy, as 
well as Bex1 knockout mouse, a newly-studied model for investigating the novel 




facilitate understanding the cellular and molecular regulatory network in muscle 
development and regeneration but also shed light on providing therapeutic 
avenues for the prevention and treatment of muscle diseases.  
4.2 Future Directions 
In this dissertation, Notch signaling pathway and Bex1 were identified with 
altered expression levels during muscle regeneration. This is supported by the 
fact that both the Notch signaling pathway and Bex1 were up-regulated in 
dystrophic muscles (Turk et al., 2005). Furthermore, this dissertation introduced 
the Notch signaling pathway and Bex1 into the regulatory network during specific 
phases of myogenesis. In detail, Chapter 2 presented that the Notch signaling 
pathway promoted self-renewal capacity of satellite cells and inhibited myogenic 
differentiation whereas Chapter 3 elaborated that Bex1 boosts myoblast fusion 
with myotubes during myogenic differentiation. Besides, this dissertation did not 
exclude the possibility that the Notch signaling pathway and Bex1 also play 
important roles in other periods of myogenesis. Indeed, more intriguing 
hypotheses pertaining to the Notch signaling pathway and Bex1 in muscle 
remain unsolved and are worthwhile for future endeavors. This chapter covers 
some relevant hypotheses based on the aforementioned studies. 
4.2.1 Notch in Skeletal Muscles 
Notch signaling pathway is evolutionarily conserved and has been 
previously implicated in cell proliferation and differentiation as well as cell fate 
determination (Artavanis-Tsakonas et al., 1999). In the myogenesis, it was 




myoblasts then to myotubes (Conboy and Rando, 2002; Kitzmann et al., 2006). 
In the satellite cells, Notch is highly active in promoting self-renewal capability 
through direct regulating Pax7 and inhibiting premature myogenic differentiation 
partially by targeting MyoD (Wen et al., 2012). Conversely, the mouse with Notch 
blockage in satellite cells displays dystrophic muscle phenotypes and spoiled 
muscle regeneration (Lin et al., 2013).  
Consistently, Chapter 2 in this dissertation proved that Notch signaling 
pathway in MDX was disturbed, which led to the self-renewal defects and 
progressive depletion of satellite cell pool. Constitutive activation of Notch 
rescued the self-renewal defect but deteriorated muscle regeneration, which was 
largely attributable to the lasting inhibition of myogenic differentiation (Wen et al., 
2012). Nevertheless, this study pointed to a crucial role of Notch in maintaining 
the pool size of satellite cells for long-term treatment of DMD.  
Furthermore, given that muscle regeneration could be improved by the 
temporarily activation of Notch through the antibody against Notch 1 receptor 
(Conboy et al., 2003), we interpret that Notch activation within a short time period 
may be a promising direction when Notch is manipulated to treat muscular 
dystrophy. To do that, the proteins of Notch ligands can be synthesized. And, the 
pharmacological activators of Notch can be developed. These reagents will 
activate Notch temporarily, and facilitate satellite cell self-renewal without 
progressively blocking myogenic differentiation. Besides, one potential 




transplantation, which might increase the cell survival rate and contribute muscle 
regeneration more efficiently. 
Another interesting future endeavor can be made to search for new target 
to balance the self-renewal and myogenic differentiation of satellite cells. As the 
Wnt signaling pathway is also highly active in muscle regeneration and plays 
roles in antagonizing the Notch pathway to initiate terminal differentiation. Notch 
pathway activation combined with Wnt pathway manipulation may be conducive 
to improve muscle pathology of MDX in terms of not only rescuing self-renewal 
but also promoting myogenic differentiation. This could be feasible thanks to the 
bridging roles of GSK3-β between Notch and Wnt pathways as GSK3-β can not 
only interact with NICD to regulate Notch target genes but also plays pivotal roles 
in stabilizing β-catenin to activate Wnt signaling pathway (Espinosa et al., 2003; 
Foltz et al., 2002). Therefore, manipulation of GSK3-β in myogenic lineage cells 
in a spatiotemporal manner could be promising in the treatment of dystrophic 
muscle in the both long term and short term runs. 
4.2.2 Bex1 in Skeletal Muscles 
As a novel gene studied in muscle development and regeneration, Bex1 
has a relatively specific functional pattern as the expression of Bex1 is limited to 
the stage of myogenic differentiation, which is evidenced by the observation of 
both in vivo and in vitro in Chapter 3. Chapter 3 also reported that Bex1 has no 
dramatic regulatory effects on the expression of myogenic differentiation markers, 
such as myogenin and MHC. Interestingly, Bex1 could positively regulate 




in both muscle development and muscle regeneration. The fusion process 
requires a series of cellular events including migration, alignment, adhesion and 
membrane fusion. It is still completely unknown in which specific stages of fusion 
Bex1 is involved.  
Currently, although various signaling pathways and transcriptional factors 
have been identified to regulate the fusion process, the cellular and molecular 
mechanism of myoblast fusion is still largely unknown. A good study model of 
myoblast fusion is Drosophila, wherein researchers have characterized two 
parallel signaling pathways of Mbc (myoblast city)/Rac and Loner/Rac (Chen et 
al., 2003; Hakeda-Suzuki et al., 2002; Rushton et al., 1995). Due to the 
conservation of muscle fusion regulation through species, those two pathways 
also have significant relevance to study myoblast fusion in mammals. As such, it 
will be of interest to target the interaction of Bex1 with potential players in these 
two pathways.  
The current cellular and molecular knowledge of Bex1 has elicited us to 
hypothesize that Bex1 could regulate myoblast fusion through these well-
established signaling pathways. For instance, the interaction of Bex1 and 
calmodulin suggested that Bex1 may be implicated in the calcium signaling 
pathway (Koo et al., 2007), which has been corroborated to regulate fusion 
through various targets, including NFATc2 isoform and N-cadherin (Horsley et al., 
2003; Mege et al., 1992). Of note, the calcium-dependent N-cadherin could 
interact with Loner to mediate the fusion process (Dottermusch-Heidel et al., 




investigation of how Bex1 regulates myoblast fusion should be attempted 
according to the biochemistry and cellular biology knowledge associated with 
Bex1.  
Besides the roles of Bex1 in the fusion characterized in this dissertation, 
there might be other intriguing hypotheses about Bex1 in the muscle 
regeneration. For example, Bex1 is abundantly expressed in neurons, which are 
closely related to muscle development and regeneration. The motor neuron and 
its innervated muscle fibers comprise the motor unit. The motor neurons play key 
roles in the muscle function as well as muscle growth, especially the distribution 
of muscle fiber types (Burke et al., 1971; Calabria et al., 2009; Sohal and Holt, 
1980). As Bex1 knockout mice displayed a compromised endurance in the 
Treadmill-running tolerance test (24% lower than WT) (Koo et al., 2007), it is 
plausible to hypothesize that the absence of Bex1 might lead to deficient motor 
neurons, which consequently impairs the muscle performance. These studies 
might have great implications in searching for therapeutic targets for the 
treatment of neuromuscular diseases as well as other metabolic diseases.     
4.3 Conclusion 
This dissertation focused on the roles of the Notch signaling pathway and 
Bex1 in the muscle regeneration. In this chapter, more intriguing hypotheses 
have been covered in this chapter and requires further studies to verify. With the 
increasingly understanding of muscle biology and more advanced technologies in 




results will definitely enrich our scope of knowledge about the cellular and 
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Research Experience 
 Characterizing satellite cell behaviors in muscular dystrophy. 
 Analyzing microRNAs in muscular dystrophy. 
 Investigating the mechanism of fiber type switch in Pax7 knock-out mice. 
 Investigating the role of Bex1 in skeletal muscles. 
 Exploring the regulation of satellite cells by extracellular matrix. 
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